{"path":"Boxes/Temple College Nursing Program/LVN Program/Fall 24/Pharmacology/Assignments/Pharmacology Bundle study guide by ScrubStudies1.pdf","text":"Pharmacology Study Guide Endocrine Medications 22 Pituitary Drugs 22 Thyroid Drugs 23 Antithyroid Drugs 23 Corticosteroids 24 Diabetes Drugs 25 Insulins 25 Oral Diabetic Drugs 26 Biguanide 26 Sulfonylureas 26 Glinides 26 Glitazones 26 Female Sex Hormones 28 Estrogens 28 Progestins 28 Male Sex Hormones 29 Androgens 29 Gastrointestinal Medications 30 Antacids 30 H2 Receptor Antagonists 30 PPIs 31 Sucralfate 31 Antidiarrheals 32 Drugs for Irritable Bowel Syndrome 32 Laxatives 33 Antiemetics 34 Respiratory Medications 35 Antihistamines 35 Decongestants 35 Antitussives 36 Expectorants 36 Bronchodilators 37 Beta-adrenergic agonists 37 Anticholinergics 37 Xanthine Derivatives 37 Nonbronchodilating 38 Leukotriene Receptor Antagonists 38 Corticosteroids 38 Analgesic Drugs 2 Opioid Analgesics 2 Nonopioid Analgesics 3 Acetaminophen (Tylenol) 3 NSAIDs 4 Anesthetics 5 General anesthetics 5 Drugs for moderate sedation 5 Local anesthetics 6 Neuromuscular Blocking Drugs 6 Antibiotics 8 Sulfonamides 8 Cephalosporins 8 Penicillins 9 Tetracyclines 9 Macrolides 9 Aminoglycosides 10 Quinolones 10 Cardiovascular Medications 12 ACE Inhibitors 12 Beta Blockers 12 ARBs 13 CCBs 13 Vasodilators 14 Alpha1 Blockers 14 Loop Diuretics 15 Potassium-Sparing Diuretics 15 Thiazides 16 Cardiac Glycosides 16 Antidysrhythmics 17 Anticoagulants 18 Antiplatelets 19 Thrombolytic Drugs 19 Statins 20 Bile Acid Sequestrants 20 Niacin 21 Fibrates 21 Psychotropic Drugs 40 Antianxiety & Hypnotic Drugs 40 Benzodiazepines 40 Z-Hypnotics 40 Doxepin 40 Melatonin Receptor Agonists 40 Suvorexant 41 Buspirone 41 Antidepressant Drugs 41 SSRIs 41 NaSSAs 42 Serotonin Modulator & Stimulator 42 SARIs 42 NDRIs 42 TCAs 43 SNRIs 43 MAOIs 43 Mood Stabilizers 44 Lithium 44 Anticonvulsant Drugs 44 Valproate 44 Carbamazepine 44 Lamotrigine 44 Drug Tx for ADHD 45 Psychostimulants 45 Nonstimulants 45 Antipsychotic Drugs 45 FGAs 45 SGAs 46 Side effects of antipsychotics 46 Alzheimer's Dz Drug Tx 47 Cholinesterase Inhibitors 47 NMDA Receptor Antagonist 47 Table of Contents Analgesic Drugs Analgesics - meds that relieve pain without causing loss of consciousness; consist of opioids and nonopioids Patient-controlled analgesia (PCA) - patient is able to self- medicate by pressing a button on a PCA infusion pump Opioid tolerance - state of adaptation; exposure to a drug causes changes in drug receptors that result in decreased drug effects over time Analgesic ceiling effect - drug reaches a maximum analgesic effect; analgesia does not improve with higher dose Adjuvant drugs - assist the primary drugs in relieving pain; help decrease amount of opioids used and adverse effects; e.g. NSAIDS, antidepressants, antiepileptic drugs; corticosteroids 3-step analgesic ladder - Step 1: use of nonopioids (with or w/o adjuvant meds) Step 2: use of opioids (with or w/o nonopioids or adjuvant meds) Step 3: use of opioids indicated for moderate to severe pain (with or w/o nonopioids or adjuvant meds) Agonists: bind to opioid pain receptor in the brain and causes an analgesic response Agonists-Antagonists (partial agonists): bind to opioid pain receptor and causes a weaker pain response Antagonists (nonanalgesics): binds to a pain receptor but does not cause analgesic response (competes with agonist or agonist-antagonist) Alleviate moderate to severe pain Combined with anesthetic during surgery Management of postoperative and procedural pain For long-term pain mngt (transdermal fentanyl) Cough suppression (codeine, hydrocodone) Diarrhea Reverse respiratory depression secondary to opioid overdosage (Naloxone) Severe asthma Caution: respiratory insufficiency; morbid obesity; sleep apnea; myasthenia gravis; paralytic ileus; pregnancy All have strong potential for abuse CNS depression (may lead to respiratory depression) Nausea; vomiting; constipation Hypotension; bradycardia Itching; rash; pruritus Urinary retention Alcohol Antihistamines Barbiturates Benzodiazepines Phenothiazine Other CNS depressants MAOIs Mechanism of Action: Indications: Contraindications: Adverse effects: Interactions: Opioid Analgesics alfentanil (Alfenta) codeine sulfate fentanyl (Duragesic, Oralet, Actiq) heroin hydrocodone (Hysingla, Vicodin [with acetaminophen]) hydromorphone (Dilaudid) meperidine hydrochloride (Demerol) methadone hydrochloride (Dolophine) morphine sulfate (Kadian, MS Contin) oxycodone (Oxy IR, OxyContin, Percocet [with acetaminophen]) remifentanil (Ultiva) sufentanil (Dsuvia, Sufenta) buprenorphine (Buprenex) butorphanol (Stadol) nalbuphine (Nubain) pentazocine (Talwin) naloxone hydrochloride (Narcan) Opioid Agonists: Opioid Agonists-Antagonists: Opioid Antagonists: Black Box Warning High potential for abuse and respiratory depression Risk of combined use with benzodiazepines: extreme sleepiness, respiratory depression, coma, death Analgesic Drugs Mild pain - use nonopioid drugs and nonpharm measures Moderate to severe pain - use opioids using stepped approach Check 9 rights and administer as ordered before pain gets out of control Monitor vitals with special attn to any respiratory changes; 10- 12 breaths/min must be reported to prescriber Naloxone must always be available Monitor UO, bowel sounds, pupillary reaction to light (pinpoint pupils indicate a possible overdose) Must know equianalgesia (able to compare meds and give comparable analgesia) Give oral dose with food Chewing or crushing of any extended-release opioid drug can cause oversedation, respiratory depression and even death May need antiemetic if N/V Keep bedside rails up and call bell within reach to prevent falls/injury related to opioid use Morphine - if decline in pt's condition or abnormal vitals- withhold drug and contact prescriber Patch - apply to clean, nonhairy area; use new site when changing; clean old site thoroughly before applying new patch; monitor for contact dermatitis; maintain pain journal at home Considerations / Patient Education IV dosing - monitor pain levels, response to meds, vitals, IV needle site, infusion rates PCA - keep track of amount/timing of doses; monitor equipment often Overdose - Naloxone via IV; diluted; administer slowly as ordered Opioid agonists-antagonists: if given at same time as other opioids leads to reversal of analgesia and acute withdrawal If pain present for >12 hours/day best to administer around the clock Each patient's pain needs are individualized Educate: Do not use alcohol or other CNS depressant Know ingredients of OTC meds For constipation: force fluids up to 3 L/day, ↑fiber, exercise, may need stool softeners Encourage to share any history of addiction May need combo of meds to control pain Report: dizziness, difficulty breathing, ↓BP, sedation, confusion, loss of memory, N/V Nonopioid Analgesics acetaminophen (Tylenol) NSAIDS Blocks peripheral pain impulses by inhibition of prostaglandin synthesis Acts on hypothalamus (regulates body temperature) Treatment of mild to moderate pain and fever Substitute for aspirin Children and adolescents with flu Severe liver disease G6PD deficiency Mechanism of Action: Indications: Contraindications: Skin disorders; N/V Hepatotoxicity; blood disorders Nephrotoxicity Adverse effects: Alcohol; phenytoin Barbiturates Warfarin Isoniazid Rifampin; beta blockers Anticholinergic drugs Interactions: Acetaminophen (Tylenol) Analgesic Drugs Block chemical activity of the enzyme cyclooxygenase (COX) Aspirin - inhibits platelet aggregation Mild to moderate headache Myalgia; neuralgia; arthralgia Alleviate postop pain Arthritis - rheumatoid, juvenile, osteo Gout; hyperuricemia Aspirin - ↓cardiac death after MI Chronic pain - bone cancer; back pain Provide opioid-sparing effect when given with opioid Risk for bleeding (Vit K deficiency, PUD); aspirin allergy Third trimester pregnancy; lactating women GI tract - Many - from heartburn to GI bleeding Acute renal failure (especially if dehydrated) ↑risk of heart attack or stroke (except aspirin) Mechanism of Action: Indications: Contraindications: Adverse effects: NSAIDS Black Box Warning All NSAIDS (except aspirin) - increased risk for heart attack or stroke All NSAIDS - increased risk for serious GI events Have analgesic, antiinflammatory and antipyretic properties aspirin (Bayer, others) celecoxib (Celebrex) ibuprofen (Motrin, Advil) indomethacin (Indocin) ketorolac (Toradol) meloxicam (Mobic, Vivlodex) nabumetone (Relafen) naproxen (Aleve, Naprosyn) Most common: Alcohol Anticoagulants Aspirin and other salicylates (w/other NSAIDS) Biphosphonates Corticosteroids Cyclosporine; lithium Diuretics and ACE inhibitors Herbals: feverfew, garlic, ginger, gingko Interactions: Type of NSAID Most common is aspirin (available OTC) Other salicylates (prescription): diflunisal (Dolobid); choline magnesium trisalicylate (Trilisate); salsalate (Salsitab) Topical form: Aspercreme Aspirin - With acetaminophen & caffeine (e.g. Excedrin) Aspirin/antacid combinations (e.g. Bufferin) Enteric-coated aspirin (e.g. Ecotrin) Indications: pain from headache, neuralgia, myalgia, arthralgia, arthritis, pleurisy, pericarditis; fever Contraindications: children and teenagers (risk of Reye's syndrome) Salicylates Acetaminophen: Monitor for chronic acetaminophen poisoning S/S: rapid, weak pulse, dyspnea, cold, clammy extremities Monitor liver fnx studies Instruct pt on how to read labels to look for acetaminophen and s/s of overdose: bleeding, loss of energy, fever, sore throat, easily bruising → report immediately Nonaspirin NSAIDs Do not crush/chew eneric-coated or sustained-released Oral forms give with food or antacids to ↓GI upset Avoid other ulcerogenic substances (e.g. alcohol, prednisone) High dose or long-term tx: monitor lab results IM injections - slowly into large muscle mass Immediately report: moderate to severe GI upset; dyspepsia with nausea, vomiting, ab pain, blood in stool or vomitus Considerations / Patient Education Aspirin: Do not give to children/teens and caution w/older adults Vinegary odor of aspirin = chemical breakdown Pt w/asthma, wheezing, respiratory problems = increased incidence of allergic reactions 'Aspirin triad' - asthma, nasal polyps and rhinitis = puts pt at risk for reactions to aspirin Cardioprotection - usually in lower doses (e.g. 81 mg) Be on lookout for s/s of aspirin toxicity: GI and other sites of bleeding and ab pain - report immediately As antipyretic - temperature will decrease in about 1 hr All NSAIDS - usually discontinue 1 week before any type of surgery including oral and dental Anesthetics Anesthetics - drugs that reduce or eliminate pain by depressing nerve function in the CNS and/or PNS. Include: General anesthetics Moderate (conscious) sedation Local anesthetics Neuromuscular blocking drugs (NMBDs) Anesthesia - state of reduced neurologic function Not 100% known; perhaps related to lipid solubility and ability to cross the blood-brain barrier to nerve cell membranes To produce unconsciousness To relax skeletal and visceral smooth muscles for surgical procedures or electroconvulsive therapy Pregnancy; narrow-angle glaucoma Acute porphyria; known susceptibility to malignant hyperthermia Hypotension; postoperative nausea and vomiting (PONV) Malignant hyperthermia - uncommon but potentially fatal; genetically linked adverse reaction to anesthesia; S/S: rapid rise in body temp, tachycardia, tachypnea, muscular rigidity; Tx: cardiorespiratory supportive care Antihypertensives; beta blockers Mechanism of Action: Indications: Contraindications (varies per med): Adverse effects (varies per med): Interactions: General Anesthetics etomidate (Amidate) ketamine (Ketalar) methohexital (Brevital) propofol (Diprivan) thiopental (Pentothal) nitrous oxide desflurane (Suprane) isoflurane (Forane) sevoflurane (Ultane) Parenteral: Inhalational Gas: Inhalational Liquid: Monitored anesthesia care (MAC) - planned procedure; pt undergoes local anesthesia along with sedation and analgesia; allows pt to be discharged soon after procedure Adjunct anesthetics - used simultaneously w/general anesthesia for anesthesia induction, sedation, reduction of anxiety and amnesia; include NMBDs, benzodiazepines, barbiturates and sedative-hypnotics among others Provides complete loss of consciousness and loss of body reflexes including respiratory muscles Requires mechanical or manual ventilatory support to avoid brain damage and suffocation Given only under controlled conditions by anesthesia providers Often uses more than 1 drug All general anesthetics have rapid onset of action and are eliminated rapidly upon discontinuation. Must be maintained intraoperatively by continuous administration of the drug. Drugs for Moderate Sedation Short-acting benzodiazepine (usually midazolam) with a short- acting opioid (usually fentanyl or morphine) Propofol Commonly used: 'Conscious sedation' or 'procedural sedation' Does not cause complete loss of consciousness and does not normally cause respiratory arrest Pt relaxes with little to no anxiety and is able to maintain airway and respond to verbal commands May cause amnesia (not 100% guaranteed) More rapid recovery time vs general anesthesia Parenteral Inhalational Anesthetics Local Anesthetics Leaves a specific portion of the body insensitive to pain by blocking nerve transmissions Affects only area where anesthetic is applied No loss of consciousness Surgical, dental, diagnostic procedures Some chronic pain Spinal during childbirth Known drug allergy Mechanism of Action: Indications: Contraindications: Spinal: spinal headache - either from inadvertent dural puncture or intrathecal anesthesia Allergic reaction - rare; s/s: skin rash, urticaria, edema, anaphylactic shock Adverse effects: bupivacaine (Marcaine, Sensorcaine) chloroprocaine (Nesacaine) lidocaine (Xylocaine) mepivacaine (Carbocaine) procaine (Novocain) tetracaine (Pontocaine) benzocaine (Dermoplast, Lanacane) dibucaine (Nupercainal) dyclonine (Dyclone, Sucrets) lidocaine (Lidoderm) Parenteral: Topical: Enflurane Halothane Epinephrine Interactions: Provides elimination of pain sensation in the tissues innervated by anesthetized nerves Does not produce paralysis of respiratory function or loss of consciousness Spinal: anesthetic drugs injected into area near spinal cord; intrathecal or epidural Peripheral: infiltration (injected into tissue); nerve block (injected at site near nerve) Parenteral Peripheral Spinal/Neuraxial Topical Neuromuscular Blocking Drugs Depolarizing - compete against acetylcholine for receptors at end of muscle nerves Nondepolarizing - block acetylcholine at receptors Maintain skeletal muscle paralysis to facilitate controlled ventilation during surgical procedure Mechanism of Action: Indications: Known drug allergy Previous h/o malignant hyperthermia Penetrating eye injuries Narrow-angle glaucoma; burns Recent CVA; crush injuries Muscle spasms (fasciculations) - may damage muscles leading to hyperkalemia Bronchospasm; hypotension Excessive bronchial and salivary secretion Contraindications: Adverse effects: succinylcholine (Anectine, Quelicin) cisatracurium (Nimbex) rocuronium (Zemuron) vecuronium (Norcuron) pancuronium (Pavulon) atracurium (Tracrium) Depolarizing: Nondepolarizing: Inhalation or local anesthetics Aminoglycosides Calcium channel blockers Clindamycin Cyclosporine Furosemide Quinidine Carbamazepine Corticosteroids Phenytoin Interactions: Produce paralysis in skeletal and smooth muscles including intercostal muscles and diaphragm → mechanical vent required before administration; High alert drug! Among most commonly used drugs in operating room for intubation with endotracheal tube or to relax skeletal muscles Do NOT cause sedation or relieve pain or anxiety: MUST be used with pain and anxiety meds Depolarizing Nondepolarizing Anesthetics Nurses do not give a nesthetics unless s/he is a n a nesthesia provider! (Exception for the topica l forms) Assess: ABCs, a lcohol use, nicotine use MUST closely ob serve pt b efore, during a nd a fter a dministra tion Focus on ABCs, vita ls, O2 sa t levels (b y pulse oximetry) a nd clinica l presenta tion Genera l a nesthesia - Assess temp (risk for ma ligna nt hyperthermia ) Ha ve resuscita tive equipment a nd meds a va ila b le Continuously monitor sta tus of b rea th sounds O2 a dministered (will need order) a fter a nesthesia a dministered Monitor supine a nd sta nding b lood pressure Monitor neurologic reflexes; response to comma nds, LOC, pupilla ry rea ction to light Monitor movement in extremities, dista l pulses, temp Pa in relief a fter a nesthesia - a dminister ca utiously (b /c a lrea dy given pa in meds with a nesthesia ) NMBDs - Ma y need more meds for seda tion a nd pa in Check vita ls a nd neurologic sta tus Educa te fa mily on need for meds to pa ra lyze for intub a tion a nd tha t pt will still b e a b le to hea r them Considera tions / Pa tient Educa tion Spina l - Consta ntly monitor for return of sensa tion a nd motor a ctivity Monitor respira tions a nd b rea thing sta tus Keep HOB eleva ted Monitor for sudden ↓in BP, vita ls, O2 sa t levels Centra l/neura xia l - Wa tch for spina l hea da che Keep pt hydra ted a nd on b ed rest Epidura l - Mea sure vita ls a nd O2 sa t levels Monitor for return of motor function a nd ta ctile sensa tion Assess touch sensa tion through ha nd pressure or gentle pinch of the skin Loca l/topica l - Do not use solutions tha t a re cloudy or discolored Ointment/crea m - clea nse a nd dry a rea to b e a nesthetized Do NOT swa llow unless prescrib er instructs Educa te - Inform pt of a nesthetic, route of a dministra tion, a dverse effects a nd specia l preca utions Discuss a ll pa tient's fea rs Instruct on posta nesthesia process: monitoring vita ls, b rea th sounds, neurologic inta ctness Encoura ge mob ility a fter procedure a s needed a nd ordered (with a ssista nce) Encoura ge to request pa in meds b efore pa in gets severe Antib iotics Ba cteria cla ssifica tion w/Gra m sta in procedure: Gra m-positive: very thick cell wa ll a nd thick outer ca psule Gra m-nega tive: sma ller cell wa ll a nd outer ca psule BUT a lso 2 cell memb ra nes: Ha rder to trea t! Sub thera peutic - when s/s do not improve w/trea tment Superinfection - when a b x reduce or completely elimina te the NORMAL b a cteria l flora Antib iotic resista nce - considered one of the world's most pressing pub lic hea lth prob lems; due to overprescrib ing of a b x a nd pt not completing regimen 3 uses of a ntib iotics: Empiric thera py: orga nism not identified yet; use a b x known to kill most common ca uses of infection Definitive thera py: once orga nism is identified, a b x thera py a djusted Broa d-spectrum a b x: a ct a ga inst gra m +, gra m - a nd a na erob ic b a cteria Na rrow-spectrum a b x: a ct a ga inst just a few orga nisms Prophyla ctic thera py: used when pt scheduled to undergo a procedure where the likelihood is high of conta mina tion (given 30 minutes b efore) Antib iotics Sulfona mides Cepha losporins Penicillins Tetra cyclines Ma crolides Aminoglycosides Quinolones Inhib it growth of b a cteria b y preventing b a cteria l synthesis of folic a cid UTIs; respira tory tra ct infections Prophyla xis for HIV pts; outpa tient Sta ph infections KDA; pregna nt women a t term Infa nts younger tha n 2 months Pa tients with G6PD or slow a cetyla tion Mecha nism of Action: Indica tions: Contra indica tions: Sulfona mides Sulfa methoxa zole comb ined with trimethoprim (Ba ctrim, Septra , SMZ-TMP) All a ntib iotics decrea se the effectiveness of ora l contra ceptives Allergic rxn (s/s: fever followed b y ra sh) Photosensitivity GI: N/V; dia rrhea ; pa ncrea titis; hepa totoxicity Convulsions; crysta lluria ; hea da che; urtica ria ; cough Sulfonylurea s; phenytoin; wa rfa rin; ora l contra ceptives Adverse effects: Intera ctions: Interfere with b a cteria l cell wa ll synthesis Structura lly a nd pha rma cologica lly rela ted to penicillins Semisynthetic *Broa d spectrum* Surgica l prophyla xis; sta phylococca l infections Meningitis; pneumonia Intra a b domina l infections; difficult UTIs KDA to penicillin a nd cepha losporins Mecha nism of Action: Indica tions: Contra indica tions: Cepha losporins cefa zolin (Ancef) cepha lexin (Keflex) cefoxitin (Mefoxin) cefuroxime (Zina cef, Ceftin) ceftria xone (Rocephin) cefta zidime (Cepta z, Forta z) cefepime (Ma xipime) cefta roline (Tefla ro) *All b egin with cef- First genera tion Second genera tion Third genera tion Fourth genera tion Fifth genera tion Mild dia rrhea ; a b cra mps; ra sh; pruritus; edema Alcohol; a nta cids; iron; prob enecid Ora l contra ceptives Adverse effects: Intera ctions: Five genera tions; gra m-nega tive covera ge increa ses with ea ch successive genera tion Antib iotics Interfere with b a cteria l cell wa ll synthesis Prevention a nd tx of infections ca used b y susceptib le b a cteria Usua lly kill gra m-positive b a cteria KDA Aminoglycosides; methotrexa te NSAIDs; ora l contra ceptives Prob enecid; rifa mpin; wa rfa rin Mecha nism of Action: Indica tions: Contra indica tions: Intera ctions: Penicillins penicillin G pota ssium (Pfizerpen) penicillin V pota ssium (Pen-Vee K) cloxa cillin (Cloxa pen) dicloxa cillin (Dycill, Dyna pen) na fcillin (Na llpen) oxa cillin (Ba ctocill) a moxicillin (Amoxil) a mpicillin (Omnipen) pipera cillin (Pipra cil) tica rcillin (Tica r) ca rb enicillin (Geocillin) a mpicillin & sulb a cta m (Una syn) a moxicillin & cla vula nic a cid (Augmentin) tica rcillin & cla vula nic a cid (Timentin) pipera cillin & ta zob a cta m (Zosyn) Comb ined w/b eta -la cta ma se inhib itor: Urtica ria ; pruritus; a ngioedema Letha rgy; a nxiety; depression N/V; dia rrhea ; ta ste a ltera tions Anemia ; gra nulocytopenia Hyperka lemia ; hyperna tremia Adverse effects: Be a wa re: Ma ny penicillin na mes end in -cillin b ut not the tra de na me Inhib it protein synthesis in b a cteria Syphilis; Lyme disea se; SIADH; cholera Pelvic infla mma tory disea se; a cne Rocky Mounta in spotted fever Typhus; mycopla sma pneumonia Anta cids; a ntidia rrhea ls; da iry products; ca lcium Entera l feedings; iron preps Ba ctericida l a b x; ora l a nticoa gula nts Ora l contra ceptives Mecha nism of Action: Indica tions: Intera ctions: Tetra cyclines demeclocycline (Declomycin) oxytetra cycline (Terra mycin) tetra cycline (Ala -tet, Brodspec, others) doxycycline (Acticla te, Adoxa , others) minocycline (Dyna cin, Minocin, others) tigecycline (Tyga cil) KDA; pregna nt or la cta ting women <8 yea rs old (will discolor teeth) Discolora tion of perma nent teeth Fetus - tooth ena mel hypopla sia ; slow feta l skeleta l development Photosensitivity Dia rrhea ; va gina l ca ndidia sis Thromb ocytopenia Coa gula tion irregula rities Ga stric upset Ma culopa pula r ra sh Contra indica tions: Adverse effects: Tetra cyclines ha ve the a b ility to b ind to diva lent a nd triva lent meta llic ions; therefore ca nnot b e a dministered with milk, a nta cids or iron sa lts (will ca use considera b le reduction in the ora l a b sorption) Inhib it protein synthesis in b a cteria Infections ca used b y streptococcus pyogenes Upper & lower resp tra ct infections ca used b y Ha emophilus influenza e Syphilis; gonorrhea ; Lyme disea se Chla mydia ; dela yed ga stric emptying in dia b etics Mecha nism of Action: Indica tions: Ma crolides a zithromycin (Aza site, Zithroma x) cla rithromycin (Bia xin) erythromycin (E.E.S. Gra nules, Ery-Ta b ) fida xomicin (Dificid) KDA Pa lpita tions; chest pa in; QT prolonga tion Hea da che; dizziness; vertigo N/V; dia rrhea ; hea rtb urn; a norexia Ra sh; urtica ria ; hea ring loss Contra indica tions: Adverse effects: Ca rb a ma zepine; cyclosporine; theophylline Wa rfa rin; moxifloxa cin Pimozide; thiorida zine Ora l contra ceptives Simva sta tin; lova sta tin Intera ctions: Antib iotics Inhib it protein synthesis in b a cteria Usua lly used in comb o with other a b x Serious gra m-nega tive infections Certa in conditions of gra m-positive cocci (usua lly given with penicillin) Prophyla xis in procedures (involving GI or GU tra ct) Surgica l pts with h/o va lvula r hea rt disea se Pedia tric - pneumonia , meningitis, UTI (serious ca ses) Ameb ic dysentery Mecha nism of Action: Indica tions: Aminoglycosides a mika cin (Amikin) genta micin (Ga ra mycin, Cidomycin) ka na mycin (Ka ntrex) neomycin (Mycifra din, Neo-Fra din) streptomycin (generic) tob ra mycin (Tob i, Neb cin) KDA Pregna nt Nephrotoxicity (reversib le) - s/s: urina ry ca sts; proteinuria ; ↑BUN a nd serum crea tinine levels Ototoxicity (va rying degrees of perma nent hea ring loss) - s/s: dizziness; tinnitus; sense of fullness in ea rs; hea ring loss Hea da che; pa resthesia ; vertigo; skin ra sh; fever Va ncomycin; cyclosporine; a mphotericin B Loop diuretics; wa rfa rin; NMBDs Contra indica tions: Adverse effects: Intera ctions: Potent! Used for virulent infections. Destroy b a cteria b y a ltering their DNA Mostly kill gra m-nega tive b a cteria Complica ted UTIs Respira tory, skin, GI, b one a nd joint infections KDA Anta cids; Ca , Mg, Fe, Zn preps; sucra lfa te; da iry - must ta ke med 1 hr b efore or a fter Entera l tub e feedings Prob enecid; nitrofura ntoin Ora l a nticoa gula nts Mecha nism of Action: Indica tions: Contra indica tions: Intera ctions: Quinolones norfloxa cin (Noroxin) ciprofloxa cin (Cipro) levofloxa cin (Leva quin) moxifloxa cin (Avelox) gemifloxa cin (Fa ctive) dela floxa cin (Ba xdela ) Ba cteria l overgrowth (long-term use) Elonga tion of QT interva l (esp. when a lso ta king a ntidysrhythmics) ↑risk for tendonitis, tendon rupture; periphera l neuropa thy; CNS effects; exa cerb a tion of mya sthenia gra vis Hea da che; dizziness; insomnia ; depression; restlessness N/V; dia rrhea ; constipa tion; hea rtb urn; fla tulence Ra sh; pruritus; urtica ria ; flushing Adverse effects: Thera peutic drug monitoring necessa ry due to the potentia l for nephrotoxicity a nd ototoxicity Dosed a ccording to level of rena l function Drug pla sma concentra tion needs to b e high (8x MIC) for b a cteria l kill → often given in 1 da ily dose Trough level mea surement ta ken 8-12 hrs a fter completion of dose a dministra tion (goa l a t or b elow 1 mcg/mL) Serum crea tinine level a lso monitored Ma y a lso give 3x/da y (pea k a nd trough levels mea sured) Lung infections - dose given via inha la tion Potent! Used for virulent infections. Bla ck Box Wa rning Quinolones ha ve increa sed risk for tendinitis a nd tendon rupture, periphera l neuropa thy, CNS effects, exa cerb a tion of mya sthenia gra vis Antib iotics Culture specimens must b e ob ta ined b efore drug thera py initia ted in order to properly ID ca usa tive orga nism Pt must ta ke a s ordered, for length of time, a round the clock Ta ke with fluids/foods a s indica ted Do not omit dose or doub le up Do not give with a nta cids, Ca supps, iron products, la xa tives with Mg Assess for rea ctions continuously (ma y ta ke a while to show up): Look for: wheezing, SOB, swelling of fa ce, tongue, ha nds, itching a nd ra sh If noted, stop dosa ge immedia tely a nd conta ct prescrib er; monitor pt Wa tch for superinfection - s/s: fever, letha rgy, mouth sores, perinea l itching Sulfona mides: Ma ke sure no a llergic rea ction to sulfa -type drugs a nd/or sulfites Avoid in pts w/G6PD a nd slow a cetyla tion Encoura ge ↑in fluids (2-3L/24 hr) Ora l doses ta ke with foods to ↓GI upset Report: worsening a b cra mps, stoma ch pa in, dia rrhea , b lood in urine, ra sh, SOB, fever Cepha losporins - Check for a llergy to penicillins (cross-sensitivity) Give with food Avoid a lcohol Doub le-check drug na mes Penicillins: Check history for a sthma , a spirin a llergy, sensitivity to cepha losporins (ma y b e higher risk for penicillin a llergy) Check for electrolyte disturb a nces (some penicillin preps ha ve ↑Na a nd K ion concentra tions) C.difficile ma y flourish in GI tra ct when ta king penicillin - prob iotics will prevent this; products with La ctob a cillus, supplements, yogurt, b uttermilk, kefir Ta ke w/a t lea st 6 oz wa ter (not juices-too a cidic) Considera tions / Pa tient Educa tion Tetra cyclines - Ma y ca use photosensitivity Ta ke ora l dose with a t lea st 8 oz fluids a nd food Ca , Mg a nd iron should b e consumed 2 hrs b efore ta king meds or consumed 3 hrs a fter meds Ma crolides - Do not give with or immedia tely b efore or a fter juices Discuss ma ny drug intera ctions with pt Report immedia tely: chest pa in, pa lpita tions, dizziness, ja undice, ra sh, hea ring loss Aminoglycosides - Ensure a dequa te hydra tion; encoura ge fluid inta ke up to 3L/da y (unless contra indica ted) Dosa ge usua lly pa rentera l Neomycin only ora l form Monitor rena l function Yogurt/b uttermilk/prob iotics to help prevent superinfection Report: cha nge in hea ring, ringing in ea rs (tinnitus) or full feeling in ea rs Report: N/V with motion, a ta xia , nysta gmus, dizziness Optha lmic: wa tch for redness, b urning, itching of the eyes or redness of skin Monitor IV sites for hea t, swelling, redness, pa in or red stea king over veins Quinolones - Educa te a b out photosensitivity Instruct to ta ke a ny a ntia cids, iron, zinc preps, multivita mins or sucra lfa te 1 hr b efore or a fter meds Report: hea da che, dizziness, restlessness, dia rrhea or vomiting, ora l ca ndidia sis, flushing of fa ce; infla mma tion of the tendons Considera tions Pa tient Educa tion Inhib it ACE (a ngiotensin-converting enzyme) ACE is responsib le for converting AI to a ngiotensin II Angiotensin II is a potent va soconstrictor a nd a lso induces a ldosterone secretion (stimula tes sodium a nd wa ter resorption); b oth increa se BP HTN, hea rt fa ilure Dia b etics with neuropa thy KDA (especia lly rxn of a ngioedema ) Ba seline K+ level of 5 mEq/L or higher Pregna nt or la cta ting women Children Pts with b ila tera l rena l a rtery stenosis Fa tigue, dizziness, mood cha nges, hea da ches Dry, nonproductive cough Loss of ta ste Hyperka lemia Angioedema Rena l impa irment or ARF Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Bla ck Box Wa rning Feta l toxicity; a void in pregna ncy Considera tions T. cla ss: Antihypertensives P. cla ss: Beta b lockers Pa tient Educa tion Block sympa thetic nervous system stimula tion b y competing with epinephrine a nd norepinephrine Ca n b e either ca rdioselective (b eta 1-b locking; ta rgets receptors on hea rt) or nonselective (b locks b oth b eta 1 a nd b eta 2-a drenergic receptors) Angina , MI, ca rdia c dysrhythmia s HTN, hea rt fa ilure Uncompensa ted hea rt fa ilure Ca rdiogenic shock, hea rt b lock or b ra dyca rdia Pregna ncy Severe pulmona ry disea se; Ra yna ud's disea se Bra dyca rdia , AV b lock, impotence Constipa tion, N/V, fa tigue, depression Dela yed hypoglycemia recovery Ma jor effects when a b ruptly stopped (precipita te a n MI, reb ound HTN) Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Bla ck Box Wa rning Do not withdra w a b ruptly T. cla ss: Antihypertensives P. cla ss: ACE Inhib itors Ca rdiova scula r Medica tions ACE Inhib itors b ena zepril (Lotensin) ca ptopril (Ca poten) ena la pril (Va sotec) fosinopril (Monopril) lisinopril (Prinivil or Zestril) -pril moexipril (Univa sc) perindopril (Aceon) quina pril (Accupril) ra mipril (Alta ce) tra ndola pril (Ma vik) Monitor: BP, pulse, wt, I/Os Use ca ution in older pts a nd pts with rena l dysfunction Conta ct HCP immedia tely if a ngioedema occurs Discuss possib ility of impa ired ta ste a nd to a void K+ supplements Will ta ke severa l weeks to see full effects Inform pt a b out not stopping meds a nd potentia l for sexua l dysfunction Instruct: monitor da ily wts, BP a nd HR, a void sudden cha nges in position; increa se inta ke of fluids a nd fib er; low-fa t diet, modera te exercise a nd ↓stress Often used a s 1st-line drugs in tx of hea rt fa ilure a nd HTN Often comb ined a s drug product with thia zide diuretic or a CCB Ca ptopril - shortest 1/2 life; needs more frequent dose Ca ptopril a nd lisinopril - not prodrugs therefore not a ctiva ted in liver a nd good for pts w/liver dysfunction Diuretics NSAIDS Lithium K+ supplements a nd K+-spa ring diuretics Intera ctions: Beta Blockers a ceb utolol (Sectra l) a tenolol (Tenormin) b eta xolol (Kerlone) b isoprolol (Zeb eta ) ca rvedilol (Coreg) esmolol (Brevib loc) -olol la b eta lol (Tra nda te) metoprolol (Lopressor) na dolol (Corga rd) neb ivolol (Bystolic) pindolol (Visken) propra nolol (Indera l) Monitor: BP, pulse, wt, I/Os, b lood glucose if dia b etic Pulse: count a pica l for 1 full minute; BP: ta ke supine a nd sta nding Pt must not stop med a b ruptly due to potentia l for reb ound hypertension Inform pt a b out not stopping meds (see a b ove) a nd potentia l for sexua l dysfunction Instruct: monitor da ily wts, BP a nd HR, a void sudden cha nges in position; increa se inta ke of fluids a nd fib er; low-fa t diet, modera te exercise a nd ↓stress Report to HCP: HR less tha n 60 b pm; BP <100 mm Hg systolic or <80 mm Hg dia stolic or wt ga in Anta cids, a nticholinergics Digoxin, diuretics Ora l hypoglycemic drugs, insulin Intera ctions: Antihypertensives Monitor serum K+ a nd Na + levels Pt must not stop med a b ruptly due to potentia l for reb ound HTN Considera tions T. cla ss: Antihypertensives P. cla ss: ARBs Pa tient Educa tion Ca rdiova scula r Medica tions (Angiotensin II Receptor Blockers) Simila r to ACE inhib itors: b lock the b inding of AII to Type 1 AII receptors Block va soconstriction a nd secretion of a ldosterone Do not ca use cough like ACE inhib itors Hea rt fa ilure HTN Pregna nt or la cta ting women Older pa tients Pts with rena l dysfunction Chest pa in, fa tigue, wea kness Hypoglycemia , dia rrhea , a nemia Urina ry tra ct infection Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: losa rta n (Coza a r) eprosa rta n (Teveten) va lsa rta n (Diova n) irb esa rta n (Ava pro) ca ndesa rta n (Ata ca nd) olmesa rta n (Benica r) telmisa rta n (Mica rdis) a zilsa rta n (Eda rb i) -sa rta n Bla ck Box Wa rning Feta l toxicity; a void in pregna ncy K+ supplements a nd K+- spa ring diuretics (ca n ca use hyperka lemia ) NSAIDs Lithium Rifa mpin Intera ctions: Considera tions T. cla ss: Antihypertensives P. cla ss: Ca cha nnel b lockers Pa tient Educa tion Prevent ca lcium from a ssisting in contra ction of hea rt Smooth muscles rela x a nd a rteries dila te → increa sed b lood flow to hea rt a nd decrea sed SVR Angina , HTN Supra ventricula r ta chyca rdia (a s a n a ntidysrhythmic) Corona ry a rtery spa sms Afib /flutter (short-term) Migra ines; Ra yna ud's disea se Acute MI 2nd- or 3rd-degree AV b lock Hypotension Hypotension, pa lpita tions Ta chyca rdia or b ra dyca rdia Constipa tion, na usea Dyspnea , ra sh, flushing Periphera l edema Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: diltia zem (Ca rdizem, Dila cor, Tia za c, Ca rtia XT, Ma tzim LA, Ta ztia XT, Diltia XT)* Benzothia zepines a mlodipine (Norva sc)* felodipine (Plendil) isra dipine (Dyna Circ) nica rdipine (Ca rdene)* nifedipine (Ada la t, Proca rdia )* nimodipine (Nimotop) Dihydropyridines Gra pefruit juice Beta b lockers Digoxin Azole a ntifunga ls Sta tins Cla rithromycin Erythromycin HIV drugs Cyclosporine Amioda rone Intera ctions: ARBs (Ca lcium Cha nnel Blockers) -dipine; -a mil; -a zem CCBs vera pa mil (Ca la n, Isoptin, Verela n)* Phenyla lkyla mines Antihypertensives Tolera ted b est with mea ls Monitor: BP, pulse, wt, I/Os Pulse: count a pica l for 1 full minute; BP: ta ke supine a nd sta nding Pt must not stop med a b ruptly due to potentia l for reb ound HTN Inform pt a b out not stopping meds a b ruptly a nd potentia l for sexua l dysfunction Instruct: monitor da ily wts, BP a nd HR, a void sudden cha nges in position; increa se inta ke of fluids a nd fib er; low-fa t diet, modera te exercise a nd ↓stress Report a ny unusua l dyspnea , dizziness, excessive fa tigue Monitor: BP, pulse, wt, I/Os, for edema a nd SOB Pulse: count a pica l for 1 full minute; BP: ta ke supine a nd sta nding Pt must not stop med a b ruptly due to potentia l for reb ound HTN If on nifedipine - follow a dmin orders ca refully (esp. dosa ge) a nd closely monitor vita ls Pa y close a ttention if pa tient ha s history of: hypotension, pa lpita tions, ta chy/b ra dyca rdia , constipa tion, dyspnea , edema Inform pt a b out not stopping meds a b ruptly a nd potentia l for sexua l dysfunction Instruct: monitor da ily wts, BP a nd HR, a void sudden cha nges in position; increa se inta ke of fluids a nd fib er; low-fa t diet, modera te exercise a nd ↓stress Report a ny pa lpita tions, pronounced dizziness, na usea , dyspnea *Used for tx of chronic sta b le a ngina Considera tions T. cla ss: Antihypertensives P. cla ss: Va sodila tors Ca rdiova scula r Medica tions Act directly on a rterioles a nd/or venous smooth muscle to ca use rela xa tion a nd therefore va sodila tion, lea ding to ↓SVR HTN Hypotension, cereb ra l edema , hea d injury Acute MI, CAD Hea rt fa ilure seconda ry to dia stolic dysfunction Dia zoxide: ma ny undesira b le effects a nd ra rely used Hydra la zine: dizziness, hea da che, a nxiety, ta chyca rdia , edema , dyspnea , N/V, dia rrhea , hepa titis, SLE, Vit B6 deficiency, ra sh Minoxidil - T-wa ve EKG cha nges Nitroprusside - cya nide/thiocya na te toxicity Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: minoxidil (Roga ine) hydra la zine (Apresoline) Low incidence Intera ctions: Va sodila tors dia zoxide (Hypersta t) nitroprusside (Nitropress) Pa tient Educa tion Considera tions T. cla ss: Antihypertensives P. cla ss: Alpha b lockers Interrupt stimula tion of the SNS a t the a lpha 1- a drenergic receptors By displa cing norepinephrine (NE) or ma king receptors less receptive to NE Lea ds to a rteria l a nd venous dila tion which reduces PVR a nd b lood pressure HTN Benign prosta tic hyperpla sia Va soconstriction from Ra yna ud's disea se or a crocya nosis Extra va sa tion of va sopressors such a s epinephrine (lea king out of b lood vessels into surrounding tissue) Periphera l va scula r disea se Hepa tic a nd rena l disea se CAD, peptic ulcer, sepsis 1st-dose phenomenon: severe a nd sudden drop in BP a fter 1st dose Orthosta tic hypotension Dizziness, hea da che, constipa tion Dry mouth, sexua l dysfunction Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: phentola mine (Generic) pra zosin (Minipress) tera zosin (Hytrin) ta msulosin (Floma x) Monitor: BP, pulse, wt, I/Os Pulse: count a pica l for 1 full minute; BP: ta ke supine a nd sta nding Be a wa re of potentia l for hypotension-induced dizziness & syncope Dry mouth - encoura ge wa ter inta ke a nd use of OTC products for dry mouth Ta mulosin - pts must inform a ll HCPs of use b efore a ny surgica l procedure Pt must not stop med a b ruptly due to potentia l for reb ound hypertension Phentola mine - b eta b lockers a nd epinephrine Intera ctions: Alpha Blockers Pa tient Educa tion -a mine, -osin a lfuzosin (Uroxa tra l) doxa zosin (Ca rdura ) phenoxyb enza mine (Dib enzyline) Inform pt a b out dry mouth, ta mulosin w/surgery, not stopping meds (see a b ove) a nd potentia l for sexua l dysfunction Instruct: monitor da ily wts, BP a nd HR, a void sudden cha nges in position; increa se inta ke of fluids a nd fib er; low-fa t diet, modera te exercise a nd ↓stress Report to HCP: HR less tha n 60 b pm; BP <100 mm Hg systolic or <80 mm Hg dia stolic or wt ga in or fa inting Anything lea ding to va sodila tion must b e a voided: Alcohol inta ke, excessive exercise, hot clima tes, use of sa una s, hot tub s Ta msulosin - wa rfa rin, a ntihypertensives, erectile dysfunction meds, a lcohol 1 Antihypertensives Ba seline neurologica l a ssessment Ca ution with older pa tients (ma y ha ve prob lems with hypotension, dizziness, syncope) Hydra la zine - closely monitor pt for 10 - 80 minutes a fter injection; wa tch for s/s of SLE (systemic lupus erythema tosus) Nitroprusside - dilute! close monitoring due to it b eing a potent va sodila tor; never infuse for > 10 minutes; cya nide a nd thiocya na te toxicity seen when used for long pd a t high ra tes Monitor: BP, pulse, wt, I/Os Pt must not stop med a b ruptly due to potentia l for reb ound HTN Inform pt a b out not stopping meds a b ruptly a nd potentia l for sexua l dysfunction Instruct: monitor da ily wts, BP a nd HR, a void sudden cha nges in position; increa se inta ke of fluids a nd fib er; low-fa t diet, modera te exercise a nd ↓stress Report a ny unusua l photosensitivity, skin ra shes, CNS cha nges Bla ck Box Wa rning Nitroprusside: severe hypotension a nd cya nide toxicity Considera tions T. cla ss: Antihypertensives/Diuretics P. cla ss: Loop diuretics Ca rdiova scula r Medica tions In loop of Henle: b lock Cl- a nd Na + resorption (lea ds to loss of fluid) Also help dila te b lood vessels (↓SVR) Edema a ssocia ted with hea rt fa ilure, hepa tic or rena l disea se HTN Hyperca lcemia (to ↑rena l excretion of Ca ++) Hepa tic coma Severe electrolyte loss Dizziness, hea da ches, tinnitus, b lurred vision N/V, dia rrhea Torsemide: Agra nulocytosis, thromb ocytopenia , neutropenia Hypoka lemia , hyperglycemia , hyperuricemia Furosemide: Erythema multiforme, photosensitivity Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: b umeta nide (Bumex, Burinex) etha crynic a cid (Edecrin) Be a wa re with older pa tients a nd those with severe electrolyte loss a nd liver fa ilure Wa tch drug intera ctions Monitor da ily: BP & pulse ra te (supine a nd sta nding), I/O, wt, hydra tion sta tus, ca pilla ry refill Wa tch for: dizziness, fa inting, light-hea dedness on cha nging position; wea kness, fa tigue, tremor, muscle cra mps, cha nges in menta l sta tus; cold, cla mmy skin Aminoglycosides, va ncomycin Corticosteroids, digoxin Antidia b etic drugs Intera ctions: Loop Diuretics furosemide (La six) torsemide (Dema dex) Bla ck Box Wa rning Furosemide: Severe wa ter a nd electrolyte depletion Pa tient Educa tion -ide ↑fib er a nd fluids (to a void constipa tion); ta ke diuretic in A.M. Sa fety mea sures to prevent fa lls; cha nge positions slowly Instruct on s/s of hypoka lemia : a norexia , na usea , letha rgy, muscle wea kness, menta l confusion, hypotension Avoid extreme swea ting; keep journa l of da ily wts a nd dosa ge Lithium NSAIDs Considera tions T. cla ss: Diuretics P. cla ss: Pota ssium-spa ring diuretics In collecting ducts a nd dista l convoluted tub ules: interfere with sodium-pota ssium excha nge Spironola ctone: Binds to a ldosterone receptors a nd b locks resorption of sodium a nd wa ter HTN, hypera ldosteronism To reverse K+ loss b y loop a nd thia zides Meta b olic a lka losis, hea rt fa ilure Hyperka lemia Severe rena l fa ilure or a nuria Severe hepa tic fa ilure Spironola ctone: gynecoma stia , a menorrhea , irregula r menses Tria mterene: decrea sed folic a cid levels, kidney stones Hyperka lemia Dizziness, hea da che Cra mps, N/V, dia rrhea Lithium ACE Inhib itors Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Intera ctions: K+ supplements NSAIDS Pota ssium-Spa ring Diuretics a miloride (Mida mor) spironola tone (Alda ctone, Ca roSpir) tria mterene (Dya zide, Ma xzide) Bla ck Box Wa rning Spironola ctone: Tumorigenic with long-term use Pa tient Educa tion AKA a ldosterone-inhib iting diuretics Wea k compa red to loop a nd thia zide diuretics Often used in comb o with thia zides Ra pid onset of a ction - good when ra pid diuresis needed Loop diuretics work even when kidney function decrea ses Diuretics Monitor da ily: BP & pulse ra te (supine a nd sta nding), I/O, wt, hydra tion sta tus Wa tch for: dizziness, fa inting, light-hea dedness on cha nging position; wea kness, fa tigue, tremor, muscle cra mps, cha nges in menta l sta tus; cold, cla mmy skin Wa tch for s/s of hyperka lemia : N/V, dia rrhea Educa te on s/s of hyperka lemia Instruct on ↑K+ foods a nd to a void overea ting ↑fib er a nd fluids (to a void constipa tion); ta ke diuretic in A.M. Sa fety mea sures to prevent fa lls; cha nge positions slowly Avoid extreme swea ting; keep journa l of da ily wts a nd dosa ge Considera tions T. cla ss: Diuretics P. cla ss: Thia zide diuretics In dista l convoluted tub ule: inhib it the resorption of Na +, K-, Cl- lea ding to osmotic wa ter loss Direct rela xa tion of a rterioles lea ding to ↓PVR HTN; edema DI; idiopa thic hypoca lciuria Hea rt fa ilure; hepa tic cirrhosis Hepa tic coma Anuria Severe rena l fa ilure ↓K+ a nd Na + levels ↑Ca ++, lipids, glucose, uric a cid Dizziness, hea da che, b lurred vision Anorexia , N/V, dia rrhea Impotence, urtica ria Ja undice, leukopenia Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Ora l hypoglycemics Corticosteroids Digoxin LIthium NSAIDS Intera ctions: Pa tient Educa tion Considera tions T. cla ss: Inotropes P. cla ss: Ca rdia c glycosides Ca rdiova scula r Medica tions Inhib it Na -K ATP pump which ca uses Na + & Ca ++ concentra tion to ↑lea ding to enha nced myoca rdia l contra ctility Increa ses dia stolic filling b etween hea rt b ea ts Decrea ses ra te of electrica l conduction (SA node to AV node) Systolic hea rt fa ilure Atria l fib rilla tion 2nd- or 3rd-degree hea rt b lock Ventricula r fib rilla tion Hea rt fa ilure from dia stolic dysfunction Bra dyca rdia or ta chyca rdia ; hypotension Hea da che, fa tigue, confusion, convulsions Unusua l color vision (green/yellow); ha lo vision Anorexia , N/V, dia rrhea Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: digoxin (Apo-Digoxin, La noxin, La noxin Pedia tric, Toloxin) Before a dministra tion: a ssess serum electrolytes, especia lly K+ a nd Mg++ (low levels of ea ch ca n lea d to digoxin toxicity); a pica l pulse for 1 minute (hold dose if <60 or >100 b pm) Doub le-check dose! IV a dministra tion: infuse undiluted forms a t a round 0.25 mg/min or per protocol Ora l a dministra tion: do NOT give with high fib er foods NOT recommended in intra muscula r forms Incompa tib le with ma ny other meds in solution or syringe After a dministra tion: monitor closely due to na rrow ra nge b etween thera peutic a nd toxic levels Monitor: neuro cha nges, GI system, ca rdia c, visua l Frequently mea sure vita ls, serum drug levels a nd serum K+ S/S of digoxin toxicity: hea da che, dizziness, confusion, na usea , visua l disturb a nces (yellow/green/ha lo); EKG cha nges Antidote: digoxin immune Fa b pa rentera lly over 30 min or IV b olus Ma ny! Most importa nt: Amioda rone, quinidine, vera pa mil (will ↑digoxin levels b y 50%) La rge a mounts of b ra n ingested Ginseng, ha wthorn, licorice, St. John's wort Intera ctions: Ca rdia c Glycosides (Digita lis Glycosides) One of the oldest ca rdia c drugs Often used in conjunction with other meds Ha s a low thera peutic index Thia zides HCTZ - hydrochlorothia zide (Microzide, Urozide) chlorothia zide (Diuril) chlortha lidone (generic) inda pa mide (Lozide) metola zone (Za roxolyn) HCTZ - most commonly prescrib ed thia zide; often included in comb o products -a zide Diuretics & Digoxin Monitor da ily: BP & pulse ra te (supine a nd sta nding), I/O, wt, hydra tion sta tus Wa tch for: dizziness, fa inting, light-hea dedness on cha nging position; wea kness, fa tigue, tremor, muscle cra mps, cha nges in menta l sta tus; cold, cla mmy skin Wa tch for s/s of hypoka lemia Monitor levels: K-, Na +, Ca ++, lipids, glucose, uric a cid Educa te on s/s of hypoka lemia a nd hyperglycemia ↑fib er a nd fluids (to a void constipa tion); ta ke diuretic in A.M. Sa fety mea sures to prevent fa lls; cha nge positions slowly Avoid extreme swea ting; keep journa l of da ily wts a nd dosa ge *Thia zide-like diuretics* Ca rdiova scula r Medica tions Considera tions T. cla ss: Va ries, mostly Antia rrhythmics P. cla ss: Va ries Correct a b norma l ca rdia c electrophysiologic function in ma ny wa ys depending on drug: Dela y or a ccelera te repola riza tion Increa se or decrea se a ction potentia l Block SNS stimula tion to hea rt a nd therefore the tra nsmission of impulses Inhib it Ca cha nnels Ma ny ca rdia c dysrhythmia s, including: Afib a nd a tria l flutter, prema ture a tria l or ventricula r contra ctions, ventricula r ta chyca rdia WPW syndrome; long-QT syndrome 2nd- or 3rd-degree AV b lock Bundle b ra nch b lock Ca rdiogenic shock Sick sinus syndrome Hypersensitivity rea ctions N/V, dia rrhea Dizziness, hea da che, b lurred vision Ma y produce new dysrhythmia s (e.g. prolonged QT interva l) Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Monitor vita ls, especia lly BP a nd pulse - notify HCP if <60 b pm Monitor EKG for prolonged QT interva l Immedia tely report: a ngina , hypotension, lighthea dedness, loss of a ppetite, tinnitus, dia rrhea Lidoca ine: MUST verify solution is for ca rdia c use; doub le- or triple-check dosa ge! Amioda rone: ta ke with food, ma y experience photosensitivity Dofetilide: monitor EKG; report chest pa in, na usea , dia rrhea Wa rfa rin (esp. w/a mioda rone; must monitor INR if given b oth) Gra pefruit juice Digoxin Sta tins Intera ctions: Antidysrhythmics quinidine (Quinidex) disopyra mide (Norpa ce) proca ina mide (Pronestyl, Proca n) lidoca ine (Xyloca ine, Xyloca rd) phenytoin (Dila ntin) fleca inide (Ta mb ocor) propa fenone (Rythmol) All b eta b lockers a mioda rone (Nexterone, Pa cerone)* Bla ck Box Wa rning Ma ny, depending on drug: ↑morta lity, proa rrhythmic effects, stroke Pa tient Educa tion Ora l meds b etter tolera ted with food/fluids Ta ke ca re cha nging positions Avoid excessive hea t Do not stop meds a b ruptly Diet: ↑fluid a nd fib er; ↓ca ffeine Monitor: BP, pulse, wt ga in Amioda rone: sungla sses to protect eyes; notify HCP of a ny skin cha nges (b lue/gra y/ja undice/ra sh) La rge group of meds cla ssified a ccording to where a nd how they a ffect ca rdia c cells *Most widely used: a mioda rone, droneda rone, sota lol, ib utilide, dofetilide droneda rone (Multa q)* sota lol (Beta pa ce, Sorine)* ib utilide (Corvert)* dofetilide (Tikosyn)* vera pa mil (Ca la n, Isoptin, Verela n) diltia zem (Ca rdizen, Dila cor, Tia za c, Ca rtia XT, Ma tzin LA, Ta ztia XT, Diltia XT) digoxin ((Apo-Digoxin, La noxin, La noxin Pedia tric, Toloxin) a denosine (Adenoca rd) AntidysrhythmicsCa rdiova scula r Medica tions Considera tions T. cla ss: Anticoa gula nts P. cla ss: Va ries Prevent forma tion of a clot or thromb us in the clotting ca sca de Wa rfa rin - prevents vit K synthesis in GI tra ct which stops production of clotting fa ctors MI, unsta b le a ngina , a fib , long period of immob iliza tion Acute b leeding process Pregna ncy (wa rfa rin) Indwelling epidura l ca theter (LMWHs) Bleeding Hepa rin: Hepa rin-induced thromb ocytopenia (HIT) Wa rfa rin: skin necrosis, 'purple toes' syndrome Anemia , dizziness, SOB, fever Letha rgy, muscle pa in Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: For injection sites - a void a rea s within 2 inches of a ny skin opening: wounds, incisions, etc Pregna ncy - not recommended, b ut hepa rin preferred over wa rfa rin Check for a llergy to b enzyl a lcohol a nd sulfites Hepa rin not intercha ngea b le with LMWHs a nd don't give together Wa rfa rin - no denta l procedures or surgery Monitor vita ls, hea rt sounds, periphera l pulses, neurologic sta tus Notify HCP - cha nges in pulse ra te/rhythm, BP, LOC, unexpla ined restlessness (ma y b e b leeding or hemorrha ge) Hepa rin must b e given sub cuta neous or IV, NOT IM; must monitor da ily clotting studies Antidotes: Hepa rin or LMWHs: IV a dmin of prota mine sulfa te Ora l wa rfa rin: Vit K Fa ctor Xa Inhib itors: Andexxa Ma ny with wa rfa rin: a ceta minophen, a spirin, NSAIDs, some a ntib iotics a nd a ntidysrhythmics, b a rb itura tes, sta tins, etc Hepa rin: a spirin, NSAIDs, ora l a nticoa gula nts, a ntipla telets Intera ctions: Anticoa gula nts hepa rin wa rfa rin (Couma din) LMWHs (low-molecula r- weight hepa rins) enoxa pa rin (Lovenox) da ltepa rin (Fra gmin) Selective fa ctor Xa inhib itors fonda pa rinux (Arixtra ) riva roxa b a n (Xa relto) a pixa b a n (Eliquis) edoxa b a n (Sa va ysa ) b etrixa b a n (Bevyxxa ) Bla ck Box Wa rning Bleeding risk; a void prema ture discontinua tion; pregna ncy (wa rfa rin) Pa tient Educa tion Direct thromb in inhib itors huma n a ntithromb in III (Thromb a te) lepirudin (Refluda n) a rga trob a n (Arga trob a n) b iva lirudin (Angioma x) da b iga tra n (Pra da xa ) Anticoa gula nts Ora l meds: ta ke with food/fluids Recommended: wt control; smoking cessa tion; control BP, ↓stress Ta ke meds a s prescrib ed Report: a ny b leeding, severe hea da che, b lurred vision, vomiting b lood, dizziness/fa inting; fever; ↓UO or da rk; ringing in ea rs, edema , b lurred vision If on wa rfa rin: Monitor Vit K inta ke; keep sa me a mount ea ch da y; a void a lcohol a nd cra nb erry juice Avoid: tight-fitting clothes, crossing legs, sitting for too long, sha rp ra zors (a s clot-preventive mea sures) Ca rdiova scula r Medica tions Considera tions T. cla ss: Antipla telet drugs P. cla ss: Va ries Prevent pla telet a dhesion a t the site of b lood vessel injury Stroke prevention (a spirin) To decrea se risk for thromb otic stroke a nd TIA Post-MI; a cute unsta b le a ngina PVD; intermittent cla udica tion Thromb ocytopenia , a ctive b leeding, leukemia Tra uma tic injury, GI ulcer, vit K deficiency Recent stroke Drowsiness, dizziness, confusion, flushing, hea da che N/V, GI b leeding, chest pa in, edema , a b pa in Ra sh, pruritus Bra dyca rdia , hypotension Thromb ocytopenia , a gra nulocytosis, leukopenia , neutropenia Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Withhold 5-7 da ys b efore pa tient undergoes surgery Aspirin - not for children a nd teena gers, in pt with b leeding disorder, pregna nt or la cta ting women, pa tients with vit K deficiency or PUD Monitor for a ny b leeding: epista xis, hema turia , hema temesis, excessive b ruising, b leeding gums, b lood in stools Monitor pla telet count: Report if a t or b elow 80,000 cells/mm3 Dipyrida mole - clopidogrel, a spirin, other NSAIDs Aspirin - steroids, nona spirin NSAIDs, hepa rin Intera ctions: Antipla telets a spirin dipyrida mole (Persa ntine) clopidogrel (Pla vix) pra sugrel (Effient) tica grelor (Brilinta ) pentoxifylline (Trenta l) Bla ck Box Wa rning Increa sed b leeding risk Pa tient Educa tion cilosta zol (Pleta l) vora pa xa r (Zontivity) tirofib a n (Aggra sta t) eptifib a tide (Integrilin) a b cixima b (ReoPro) Considera tions T. cla ss: Thromb olytics P. cla ss: Va ries Brea k down thromb i in the corona ry a rteries b y a ctiva ting the conversion of pla sminogen to pla smin Presence of thromb us tha t interferes significa ntly with norma l b lood flow in the hea rt Acute MI, a rteria l thromb osis, DVT Occlusion of shunts or ca theters, PE Acute ischemic stroke Concurrent use of other drugs tha t a lter clotting Interna l, intra cra nia l a nd superficia l b leeding Hypersensitivity, a na phyla ctoid rea ctions N/V, hypotension Ma y induce ca rdia c dysrhythmia s Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Do not use IM injections (due to risk of b leeding) Monitor: dra ina ge, urine, stool, emesis, sputum, secretions for b lood Monitor vita ls, report ta chyca rdia or ↓in BP; a lso report decrea se in hemoglob in or hema tocrit Monitor INR, a PTT, pla telet counts a nd fib rinogen levels no la ter tha n 2-3 hrs post-a dministra tion Report: b leeding from gums/mucous memb ra nes, epista xis, hema turia , b lood in stool Concurrent use of a nticoa gula nts or a ntipla telet a gents Intera ctions: Thromb olytic Drugs a ltepla se (Activa se) tenectepla se (TNKa se) Pa tient Educa tion Notify HCP if: Pink, red or cloudy urine; Bla ck, ta rry or red stools Ab or chest pa in, dizziness, severe hea da che -pla se Antipla telets & Thromb olytics Aspirin - ta ke w/6-8 oz wa ter a nd food; rema in upright 30 min a fter Cha nge positions slowly Report: unusua l or excessive b leeding, severe hea da che, b lurred vision, vomiting b lood, dizziness, fever, ra sh Considera tions Inhib it the enzyme HMG-CoA reducta se (which is necessa ry for liver to produce cholesterol) This decrea ses ra te of cholesterol production a nd reduces pla sma concentra tions of LDL cholesterol Hypercholesterolemia (esp ↑LDL); first-line drug thera py Pregna ncy Liver disea se, eleva tion of liver enzymes Ab pa in, ra sh, hea da che - most common Eleva ted liver enzymes Myopa thy (muscle pa in) which ma y lea d to rha b domyolysis Dizziness, b lurred vision, fa tigue Constipa tion, dia rrhea , na usea Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: lova sta tin (Altoprev) pra va sta tin (Pra va chol) simva sta tin (Zocor) a torva sta tin (Lipitor) Pa tient Educa tion Considera tions T. cla ss: Antilipemics P. cla ss: Bile a cid sequestra nts cholestyra mine (Preva lite) colestipol (Colestid) colesevela m (Welchol) Pa tient Educa tion Antihyperlipidemics T. cla ss: Antilipemics P. cla ss: HMG-CoA Reducta se Inhib itors Assess a lcohol inta ke due to potentia l for liver da ma ge Ta ke with a t lea st 6-8 oz wa ter or with mea ls to ↓ga stric upset Monitor for s/s of rha b domyolysis: muscle soreness, cha nge in urine color, fever, N/V, ma la ise If lipid profile ordered, instruct pt to fa st for 12-14 hrs prior Limit gra pefruit juice to < 1 qt/da y Wa rfa rin; gemfib rozil Erythromycin, a zole a ntifunga ls, quinidine, vera pa mil Amioda rone, gra pefruit juice HIV a nd hep C protea se inhib itors Cyclosporine, cla rithromycin, diltia zem, a mlodipine Intera ctions: HMG-CoA Reducta se Inhib itors (Sta tins) -sta tin fluva sta tin (Lescol) rosuva sta tin (Crestor) pita va sta tin (Liva lo, Zypita ma g) Bind b ile a nd prevent resorption of the b ile a cids from the SI which ca uses b ile a cids to b e excreted in stool Liver will then do 2 things: Convert more cholesterol to b ile a cids ↑the numb er of LDL receptors on its surfa ce which b ind to circula ting LDL a nd ↓LDL in b loodstrea m Type II hyperlipoproteinemia Pruritus a ssocia ted with pa rtia l b ilia ry ob struction (cholestyra mine) Bilia ry or b owel ob struction Phenylketonuria (PKU) Constipa tion, hea rtb urn, na usea , b elching, b loa ting Hea da che, tinnitus, b urnt odor of urine Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Assess a lcohol inta ke due to potentia l for liver da ma ge Ta ke with mea ls to a void GI upset Increa se fib er a nd wa ter inta ke to a void constipa tion If in powder form must b e mixed thoroughly with food or fluids (4-6 oz dissolved for a t lea st 1 minute); a dd wa ter if still not dissolved NEVER ta ke in dry form Note timing of drug in rela tion to other medica tions All drugs must b e ta ken a t lea st 1 hr b efore or 4-6 hrs a fter a dministra tion of b ile a cid sequestra nt High doses will decrea se a b sorption of vita mins A, D, E a nd K Intera ctions: Bile Acid Sequestra nts Educa te: ↓fa t a nd ↓cholesterol diet; modera te exercise Weight loss if needed Smoking a nd drinking cessa tion Report to HCP: a ny new symptoms, persistent GI upset, a b norma l or unusua l b leeding, muscle a ches/pa in Ca rdiova scula r Medica tions (Antilipemics) Educa te: ↓fa t a nd ↓cholesterol diet; modera te exercise Weight loss if needed Smoking a nd drinking cessa tion Report to HCP: a ny unusua l symptoms Inform pa tient most a dverse side effects disa ppea r over time Considera tions T. cla ss: Antilipemics P. cla ss: B-complex vita min Not 100% known Possib ly: inhib its lipolysis in a dipose tissue, reducing production of free fa tty a cids (FFAs) The liver norma lly uses FFAs to synthesize triglycerides ↓TG → ↓LDL concentra tions Hyperlipidemia Liver disea se, peptic ulcer Any a ctive hemorrha gic process Gout GI distress Cuta neous flushing, pruritus Blurred vision, glucose intolera nce, hepa totoxicity Mecha nism of Action: Indica tions Contra indica tions: Adverse effects: Assess a lcohol inta ke due to potentia l for liver da ma ge Ta ke NSAID 30 minutes b efore nia cin to minimize flushing Ta ke with mea ls to ↓GI distress HMG-CoA reducta se inhib itors Intera ctions: Nia cin (Nicotinic Acid) nia cin (Nia cor, Nia spa n) Pa tient Educa tion Considera tions T. cla ss: Antilipemics P. cla ss: Fib ric a cid deriva tives Activa te lipoprotein lipa se (enzyme responsib le for the b rea kdown of cholesterol) Suppress relea se of FFAs from a dipose tissue Inhib it synthesis of TG in liver Increa se secretion of cholesterol into b ile Also induce cha nges in b lood coa gula tion Hyperlipidemia b ut not first-line Severe liver or kidney disea se Cirrhosis Ga llb la dder disea se Ab discomfort, na usea , dia rrhea Hea da che, b lurred vision, ra sh ↑risk for ga llstones, hema turia , ↓urine output Prolonged prothromb in time Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Assess a lcohol inta ke due to potentia l for liver da ma ge Monitor liver, kidney function tests a nd prothromb in time Gemfib rozil will enha nce ora l a nticoa gula nts; b e ca reful with wa rfa rin Sta tins (especia lly with gemfib rozil) Fenofib ra te ma y ra ise b lood level of ezetimib e (Zetia ) Intera ctions: Fib ric Acid Deriva tives gemfib rozil (Lopid) fenofib ra te (Fenoglide, Lipofen) Pa tient Educa tion (Fib ra tes) Educa te: ↓fa t a nd ↓cholesterol diet; modera te exercise Weight loss if needed Smoking a nd drinking cessa tion Discuss side effect of flushing fa ce a nd option of NSAID dose prior to ta king med Educa te: ↓fa t a nd ↓cholesterol diet; modera te exercise Weight loss if needed Smoking a nd drinking cessa tion Antihyperlipidemics (Antilipemics)Ca rdiova scula r Medica tions Most a ugment the na tura l effects of the mimicked pituita ry hormone Octreotide a nd b romocriptine inhib it the hormone Cosyntropin: used for dia gnosis of a drenocortica l insufficiency Soma tropin, soma trem: tx of hypopituita ry dwa rfism; stimula te skeleta l growth; for wa sting a ssocia ted with HIV infection Octreotide: to a llevia te symptoms of ca rcinoid tumors Pergona l, clomiphene: increa se cha nces of pregna ncy Bromocripine: inhib its la ctogenesis Va sopressin/desmopressin: for pts with DI due to deficiency in endogenous ADH Pts with a cute or chronic illness (e.g. migra ines, epilepsy, a sthma ) Hea da che; fa tigue Hyperglycemia ; hypothyroidism Na usea ; vomiting; dia rrhea ; cra mps Dyspnea ; a rthra lgia ; hyperca lciuria Uterine cra mping Ca rb a ma zepine; lithium; a lcohol; demeclocycline Cyclosporine; thiorida zine; ciprofloxa cin Glucocorticoids Mecha nism of Action: va ry per med Indica tions: va ry per med Contra indica tions: va ry per med Adverse effects: va ry per med Intera ctions: Endocrine Medica tions Pituita ry Drugs cosyntropin (Cortrosyn) Adrenocorticotropic hormone (ACTH) menotropins (Menopur, Pergona l) Follicle-stimula ting hormone (FSH) soma tropin (Genotropin, Huma trope) Growth hormone (GH) soma trem (Protropin) Growth hormone (GH) octreotide (Sa ndosta tin) Growth hormone (GH) clomiphene (Clomid, Serophene) Luteinizing hormone (LH) b romocriptine (Pa rlodel) Prola ctin thyrotropin (Thyrogen) Thyroid-stimula ting hormone (TSH) va sopressin (Va sostrict, Pitressin) Antidiuretic hormone (ADH) desmopressin (DDAVP, Nocdurna ) Antidiuretic hormone (ADH) oxytocin (Pitocin) Oxytocin Anterior Pituita ry: Posterior Pituita ry: Drug a nd Hormone Mimicked Octreotide: Doub le-check route of a dministra tion Pa tients must report a b domina l distress Monitor glucose levels Desmopressin: Ma ny forms of a dministra tion: ora l, IV, intra na sa l, sub cuta neous Rota te sites (Sub Q a nd IM) If used in pa tients with DI, fluid inta ke ma y need to b e a djusted Va sopressin: Notify prescrib er if eleva ted BP, fever, na usea , a b cra mping worsen or persist Na sa l spra y is to b e given topica lly to the na sa l memb ra nes, not inha led Considera tions / Pa tient Educa tion Educa te on route of a dministra tion a nd a sk for return demo Suggest keeping a journa l with record of symptoms Na sa l spra y pump for intra na sa l forms of desmopressin: Prime pump b efore first use or if left unused for 1 week (depress pump 4x) One pump = 10 mcg Instruct pa rents on the potentia l for children to develop b one prob lems; b e on lookout for limping or fa voring limb s Pts with DI: wa ter inta ke needs to b e monitored Endocrine Medica tions Thyroid Drugs Mimic endogenous thyroid hormones Hypothyroidism To dia gnose hyperthyroidism (TSH- suppression test) Prevention or tx of goiters Repla cement hormone thera py when thyroid removed Recent MI Adrena l insufficiency Hyperthyroidism Mecha nism of Action: Indica tions: Contra indica tions: Synthetic: levothyroxine (T4) (Synthroid) liothyronine (T3) (Cytomel, Triosta t) liotrix (comb o of T4 & T3) (Thyrola r) Ca rdia c dysrhythmia s (worst effect) Ta chyca rdia ; pa lpita tions; a ngina ; HTN Insomnia ; tremors; hea da che; a nxiety Na usea ; dia rrhea ; cra mps; wt loss; fever Adverse effects: Usua lly from overdose Thyroid Drugs: Lifelong thera py is the norm Ta ke a t sa me time every da y to ma inta in b lood levels Ta ke once da ily, in morning on empty stoma ch a t lea st 30 minutes b efore b rea kfa st Avoid ta king within 4 hrs of: OTC preps with iodine, a nta cids, or vita mins/supplements with iron a nd/or Ca Avoid iodized sa lt a nd iodine-rich foods Bra nds of drugs ca nnot b e intercha nged! Older a dults - ma y require a decrea sed dosa ge Pts need to report: chest pa in, weight loss, pa lpita tions, tremors, swea ting, SOB immedia tely Considera tions / Pa tient Educa tion PTU: Ta ke with mea ls to decrea se GI upset Ta ke sa me time every da y Monitor liver function tests a nd CBC counts Report immedia tely: fever, sore throa t, mouth ulcers, skin eruptions Educa te on s/s of hypothyroidism: wt ga in; loss of menta l a nd physica l sta mina ; ha ir loss; firm edema ; yellow dullness of skin Iodine-rich foods: Soyb ea ns; tofu; turnips High-iodine sea food; certa in b rea ds Na tura l: thyroid, dessica ted (Armour Thyroid, Westhroid) Antithyroid Drugs Impede forma tion of thyroid hormone PTU a lso inhib its the conversion of T4 & T3 Ra dioa ctive iodine destroys thyroid gla nd b y a b la tion Hyperthyroidism Prevent surge in thyroid hormones a fter tx for hyperthyroidism or thyroid ca ncer Pregna ncy (controversia l) If necessa ry, PTU during 1st trimester then methima zole for rema inder of pregna ncy Mecha nism of Action: Indica tions: Contra indica tions: Liver a nd b one ma rrow toxicity (most serious) Drowsiness; hea da che; vertigo; na usea ; vomiting, dia rrhea Smoky urine; decrea sed UO Agra nulocytosis; leukopenia ; ra sh; mya lgia ; nephritis Bone ma rrow suppressa nts Ora l a nticoa gula nts Adverse effects: Intera ctions: Thioa mide deriva tives: methima zole propylthioura cil (PTU) Ra dioa ctive iodine (iodine-131) Pota ssium iodide Phenytoin; fosphenytoin Cholestyra mine; a nta cids; Ca sa lts; iron Estrogen; wa rfa rin Intera ctions: Endocrine Medica tions Ca ta ra cts; gla ucoma ; PUD; menta l hea lth prob lems Funga l or b a cteria l infections; other serious infections Ca ution w/pts with DB; ga stritis; reflux or ulcer disea se; hea rt fa ilure Non-K+ spa ring diuretics; a spirin Anticholinestera se drugs; immunizing b iologics Antidia b etic drugs; thyroid hormones Antifunga l meds; b a rb itura tes Hyda ntoins; wa rfa rin; ora l contra ceptives Contra indica tions: Intera ctions (systemica lly a dministered): Ca n effect a ll b ody systems Hea rt fa ilure; edema ; HTN Convulsions; hea da che; vertigo; nervousness Growth suppression; Cushing's syndrome Hyperglycemia ; psychosis (b oth very common) Adverse effects: Pedia tric pts: growth suppression ma y occur; document b a seline ht a nd wt Ca ution with older a dults (more prone to a drena l suppression) Best time to a dminister: 6-9 a .m. Prednisone a nd fludrocortisone: Give ora lly with sna ck or mea l to help decrea se GI upset Tell pts to a void a lcohol, ca ffeine a nd a spirin (to a void ulcerogenic effects) Due to immune suppression, monitor for flu symptoms, sore throa t a nd fever Avoid a b rupt withdra wa l of a ll systemic corticosteroids → ma y result in a drena l insufficiency (s/s: fa tigue; n/v; hypotension) Intra a rticula r injections: a void overuse; ice pa cks for up to 24 hrs a fter a dministra tion Considera tions / Pa tient Educa tion Na sa l spra ys: clea r na sa l pa ssa ge first Inha lers: ma y lea d to funga l infections; rinse with wa ter a fter ea ch use Report: funga l infection; hoa rseness; throa t irrita tion; dry mouth Long-term use: Be a wa re decrea sed wound hea ling ma y occur Pts must a void sick people due to ↓immune system Report: edema ; SOB; joint pa in; fever; mood swings Cha ra cteristics: a cne; b uffa lo hump; ob esity of trunk a rea ; moon fa ce; thin extremities Be ca reful to a void fa lls due to risk for osteoporosis: ta ke sufficient VIt D a nd ca lcium Missed dose: ta ke a s soon a s rememb er unless close to next dose Report wt ga in of 2 lb /24 hrs or 5 lb /week Corticosteroids Mimic endogenous corticosteroids Aid in synthesis of certa in proteins tha t exert specific effects (e.g. a nti-infla mma tory; immunosuppressive) Adrenocortica l deficiency Adrenogenita l syndrome Ba cteria l meningitis Cereb ra l edema Colla gen disea ses (e.g. lupus) Derma tologic disea ses Endocrine disorders (e.g. thyroiditis) GI disea ses (e.g. ulcera tive colitis) Mecha nism of Action: Indica tions: Glucocorticoids: a lclometa sone (Aclova te-topica l) b eta metha sone (Uticort-topica l; Celestone-systemic) b eclometha sone (Beclovent-inha led) clob eta sol (Clob ex-topica l) cortisone (Cortone a ceta te-systemic) dexa metha sone (Deca dron-systemic) fluocinolone (Ca pex-topica l) flunisolide (Aerospa n-inha led) flutica sone (Flovent-inha led) ha lob eta sol (Bryha li-topica l) hydrocortisone (Cortef-systemic; Ala - Cort-topica l) methylprednisolone (Medrol-systemic) mometa sone (Elocon-topica l; Asma nex-inha led) prednisolone (Ora pred-systemic; Prednisol-topica l) prednisone (Ra yos-systemic) tria mcinolone (Aristocort-systemic; Derma sorb -topica l) Minera locorticoids: fludrocortisone (Florinef Aceta te- systemic) Two types: Glucocorticoids Minera locorticoids Glucocorticoids a va ila b le topica l, systemic, inha led, na sa l Minera lcorticoids a va ila b le systemic Chronic respira tory illness (e.g. a sthma ) Hema tologic disorders Ophtha lmic disorders Orga n tra nspla nta tion Leukemia s a nd lymphoma s Nephrotic syndrome Rhinitis (na sa l) Infla mma tion of eye, ea r a nd skin (topica l) Peptic ulcers; pa ncrea titis Fra gile skin; petechia e Muscle wea kness; osteoporosis Gla ucoma ; wt ga in Long-term: moon fa ce Function a s sub stitute for endogenous hormone Restore pt a b ility to meta b olize ca rb s, fa ts a nd proteins; to store glucose in the liver a nd to convert glycogen to fa t stores Type I or Type II dia b etes a s needed Alrea dy hypoglycemic pt (must test BG prior to a dministra tion) Mecha nism of Action: Indica tions: Contra indica tions: All insulins a re considered high-a lert medica tions! Endocrine Medica tions Dia b etes Drugs Insulins Ora l Dia b etic Drugs Bigua nide Sulfonylurea s Glinides Glita zones Hypoglycemia from excessive insulin which could lea d to b ra in da ma ge, shock, dea th Wt ga in (most common) Lipodystrophy a t site of repea ted injections; a llergic rea ctions (ra re) Corticosteroids Estrogen Diuretics Thyroid drugs Nonselective b eta b lockers Hypoglycemic drugs Adverse effects: Intera ctions: Ra pid-a cting Short-a ctingInsulins Ra pid-Acting Intermedia te-a cting Long-a cting insulin lispro (Huma log, Ademlog) - a ppea rs clea r a nd colorless insulin a spa rt (NovoLog, Fia sp) isulin glulisine (Apidra ) Afrezza : inha led Route: Sub Q Onset of a ction: 15 minutes Pea k: 1-2 hr Dura tion: 3-5 hr Insulin Lispro: Short-Acting regula r insulin (Humulin R, Novolin R) Appea rs clea r a nd colorless Route: Sub Q Onset of a ction: 30-60 minutes Pea k: 2.5 hr Dura tion: 6-10 hr Regula r insulin: Intermedia te-Acting insulin isopha ne suspension (AKA NPH insulin) Appea rs cloudy or opa que Route: Sub Q Onset of a ction: 1-2 hr Pea k: 4-8 hr Dura tion: 10-18 hr NPH Insulin: Long-Acting insulin gla rgine (La ntus) - Appea rs clea r a nd colorless AKA b a sa l insulin Provides a prolonged, consistent BG level insulin detemir (Levemir) insulin degludec (Tresib a ) insulin gla rgine (Ba sa gla r) Route: Sub Q Onset of a ction: 1-2 hrs Pea k: None Dura tion: 24 hrs Insulin gla rgine: Detemir a nd gla rgine NOT intercha ngea b le Degludec - ultra long-a cting Fixed-Comb o Humulin 70/30 Humulin 50/50 Novolin 70/30 Ryzodeg (insulin degludec/insuln a spa rt) Huma log Mix 75/25 Huma log 50/50 Nova log 70/30 All conta in one intermedia te-a cting type a nd either a ra pid-a cting or a short-a cting Fixed comb o Bla ck Box Wa rning Afrezza - ma y ca use a cute b ronchospa sms Decrea ses glucose production b y liver Decrea ses intestina l a b sorption of glucose Improves insulin receptor sensitivity Type II dia b etes (especia lly newly dia gnosed) Predia b etes Mecha nism of Action: Indica tions: Contra indica tions: Endocrine Medica tions Dia b etes Drugs, cont. Ab b loa ting; na usea ; cra mping; feeling of fullness; dia rrhea Meta llic ta ste; hypoglycemia ; low B12 levels La ctic a cidosis (ra re) Cimetidine Diuretics Corticosteroids Contra st media (discontinue da y of test a nd 48 hrs post) Adverse effects: Intera ctions: Bigua nide Sulfonylurea s Ora l Dia b etic Drugs Glinides Glita zones Bigua nide (Metformin) First-line drug for Type II DB; most commonly used Bind to specific receptors on b eta cells in the pa ncrea s to stimula te the relea se of insulin Decrea se the secretion of gluca gon Pt must ha ve functioning b eta cells in the pa ncrea s Type II dia b etes (especia lly ea rly sta ges) NOT for Type I Hypoglycemia ; etha nol use Adva nced a ge; a llergy to sulfona mide a ntib iotics Mecha nism of Action: Indica tions: Contra indica tions: Hypoglycemia ; wt ga in Skin ra sh; na usea ; epiga stric fullness; hea rtb urn Beta b lockers; cimetidine; erythromycin; flucona zole; sulfona mide a b x; DPP4 inhib itors; ga rlic; ginger; ginseng; ca rb a ma zepine; phenob a rb ita l; phenytoin; rifa mpin Adverse effects: Intera ctions: Sulfonylurea s Oldest group of ora l DB drugs glipizide (Glucotrol) glyb uride (Dia b eta ) glimepiride (Ama ryl) Increa se insulin secretion from the pa ncrea s Short dura tion of a ction tha n Sulfonylurea s Type II DB Sa me a s sulfonylurea s Hypoglycemia ; wt ga in Sa me a s sulfonylurea s Do NOT comb ine with sulfonylurea s Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Intera ctions: Glinides repa glinide (Pra ndin) na teglinide (Sta rlix) Decrea ses insulin resista nce b y enha ncing the sensitivity of insulin receptors Inhib its glucose a nd triglyceride production in liver Slow onset of a ctivity Type II DB NY Hea rt Associa tion Cla ss III or IV hea rt fa ilure Ca ution in pts w/liver or kidney disea se Hea rt fa ilure; periphera l edema ; wt ga in Decrea sed b one density which increa ses risk for fra ctures Ketocona zole; erythromycin Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Intera ctions: Glita zones pioglita zone (Actos) AKA thia zolidinediones AKA insulin-sensitizing drugs Rena l disea se or rena l dysfunction; a lcoholism Meta b olic a cidosis; hepa tic disea se; hea rt fa ilure Bla ck Box Wa rning Ma y ca use or exa cerb a te hea rt fa ilure Endocrine Medica tions Insulin: Alwa ys check BG levels b efore a dministra tion to ma ke sure pt is not hypoglycemic Check for current meds tha t ma y intera ct, especia lly: corticosteroids, thyroid drugs, diuretics, sa licyla tes Ta ke extra ca re with U-500 insulin orders Afrezza : contra indica tions of smoking, chronic a sthma a nd COPD; a lso ha s b la ck b ox wa rning Do NOT sha ke NPH a nd premixed insulin mixtures; instea d roll b etween the ha nds (helps a void a ir in syringes) Administer insulin a t room temp b ut refrigera te in wa rm or hot clima te; never give cold a nd do not freeze Keep insulin a t room tempera ture up to 1 month; in refrigera tor up to 3 months Administer sub q a t 90 a ngle; IV a dministra tion in specia l situa tions a nd only regula r insulin Give freshly mixed insulin within 5 minutes Administer with mea ls rea dy: Ra pid-a cting 15 minutes b efore mea ls Short-a cting 30 minutes b efore mea ls NPH 30-60 minutes b efore mea ls Afrezza 20 minutes b efore mea ls Comb o products 15-30 minutes b efore mea ls Considera tions / Pa tient Educa tion Ora l Dia b etic Drugs: Give a t lea st 30 minutes b efore mea ls Bigua nides: older a dults or ma lnourished pt ma y rea ct a dversely Metformin: No contra st media Be on lookout for la ctic a cidosis: Hyperventila tion; cold, cla mmy skin; muscle pa in; a b pa in; dizziness; irregula r hea rtb ea t Weigh da ily to wa tch for edema If hypoglycemia occurs, ha ve pt: ta ke gluca gon, ea t glucose ta b lets or gel, corn syrup or honey or drink fruit juice If pt on NPO, check with prescrib er for instructions on meds Educa tion: Encoura ge pt to wea r medica l a lert b ra celet Instruct on rota tion of sites: inject sa me site for 1 week, move ~1 inch a nd inject there for 1 week Sites: front/b a ck of thigh; outer a rea of upper a rm; fa tty a rea of a b s (> 2 inches from umb ilicus) Stress glucose monitoring, exercise, foot ca re, dieta ry pla n, weight control, A1C monitoring Encoura ge nutritiona l consult Instruct to a void smoking a nd a lcohol; do not skip mea ls Educa te on s/s of hypo a nd hyperglycemia a nd situa tions tha t a ffect BG: fever, illness, stress, ↑a ctivity/exercise, surgery, emotiona l distress Report: yellow discolora tion of skin, da rk urine, fever, sore throa t, wea kness, unusua l b leeding or b ruising Dia b etes Drugs, cont. Fema le Sex Hormones Estrogens Mimic endogenous hormones Effects such a s: regula te production of FSH a nd LH; promote development of fema le seconda ry sex cha ra cteristics; initia tion of menses Tx for menopa usa l symptoms (most common) Hypogona dism; a trophic va ginitis Ora l contra ception; uterine b leeding Estrogen-dependent ca ncer; pregna ncy Undia gnosed a b norma l va gina l b leeding Active thromb oemb olic disorder Mecha nism of Action: Indica tions: Contra indica tions: conjuga ted estrogens (Prema rin) esterified estrogens (Estra ta b ) estra diol tra nsderma l (Estra derm, Clima ra , Vivelle) estra diol cypiona te (Depo-Estra diol, DepoGen) estra diol va lera te (Delestrogen) ethinyl estra diol (Estinyl) estra diol va gina l dosa ge forms (Va gifem, Estra ce Va gina l Crea m) estrone (Estrone Aqueous) estropipa te (Ogen, Ortho-Est) Thromb oemb olic events Risk of certa in ca ncers; CV disorders; dementia Na usea (most common); dia rrhea ; vomiting; photosensitivity HTN; edema ; a menorrhea ; chloa sma Ora l a nticoa gula nts; rifa mpin; TCAs St. John's wort; smoking Adverse effects: Intera ctions: Estrogens: Ta ke sa me time every da y with food Estra diol pa tch: a pply to lower a b s (not b rea sts or chest) Discuss b la ck b ox wa rning risks Closely monitor pa tients who smoke due to increa sed risk for thromb olytic events Report: HTN; edema ; thromb oemb olism; migra ines; depression; b rea kthrough b leeding; wt ga in of 2 lb s/24 hrs or 5 lb s/week Hormones ma y increa se sensitivity to sunlight Considera tions / Pa tient Educa tion Progestins Mimic endogenous hormones Effects such a s: decrea sed endometria l prolifera tion; increa se in b a sa l b ody temp; thickening of va gina l mucosa ; rela xa tion of uterine smooth muscle Functiona l uterine b leeding Amenorrhea Prevention of contra ception PMS; fema le infertility Sa me a s estrogens Mecha nism of Action: Indica tions: Contra indica tions: hydroxyprogesterone (Hylutin) levonorgestrel (Pla n B) medroxyprogesterone (Provera , Depo- Provera ) megestrol (Mega ce) norethindrone a ceta te (Aygestin) norgestrel (Ovrette, Ovra l) progesterone (Prometrium) etonogestrel impla nt (Impla non) Liver dysfunction Thromb oemb olic disorders Risk of certa in ca ncers, CV disorders; dementia Na usea ; vomiting; a menorrhea Bone density loss (Depo-Provera ) Benzodia zepines; voricona zole Ba rb itura tes; ca rb a ma zepine Phenytoin; rifa mpin St. John's wort Antidia b etic drugs Adverse effects: Intera ctions: Bla ck Box Wa rning Estrogens a nd Progestins: risk for endometria l ca ncer, ca rdiova scula r disorders, b rea st ca ncer a nd dementia Depo-Provera : risk for loss of b one density Progestins Be a wa re of potentia l for intera ction with a ntidia b etic drugs Depo-Provera : one IM injection every 3 months; give in deep muscle ma ss a nd rota te sites Megestrol: given a s a ppetite stimula nt for a norexia a nd unexpla ined weight loss in AIDs pa tients Ma le Sex Hormones Androgens a nd others Mimic endogenous hormones Effects such a s: stimula te norma l growth of ma le sex orga ns a nd development of ma le seconda ry sex cha ra cteristics Will ca use the relea se of endogenous testosterone to b e inhib ited; ma y suppress sperm production a nd lea d to infertility Prosca r inhib its the conversion of testosterone Sildena fil rela xes muscle of penis to permit flow BPH; a ngioedema ; ma le a ndrogenetic a lopecia Ma le hypogona dism; erectile dysfunction Postpub erta l cryptorchidism Prosta te ca ncer ED drugs: CV disorders; nitra tes Fina steride: women a nd children Mecha nism of Action: Indica tions: Contra indica tions: Na tura l: testosterone (Androderm) Synthetic: methyltestosterone (Android) fluoxymesterone (Ha lotestin) Synthetic a na b olic steroids: oxymetholone (Ana drol-50) oxa ndrolone (oxa ndrin) Androgen inhib itors: fina steride (Prosca r) duta steride (Avoda rt) Phosphodiestera se inhib itors: sildena fil (Via gra ) va rdena fil (Levitra ) ta da la fil (Cia lis) Androgenic steroids: Fluid retention Ra re: peliosis of the liver; liver ca ncer ED drugs: Ma y decrea se BP in pt w/CV disea se ta king nitra tes Hea da ches; flushing; dyspepsia Fina steride: Loss of lib ido; loss of erection; eja cula tory dysfunction Adverse effects: Ta ke testosterone a t regula r interva ls Testoderm: a pply to clea n, dry, sha ven scrota l skin Androderm pa tches: b a ck, a b domen, upper a rms or thighs a nd a void b ony a rea s a nd scrotum Androgel: a pply to shoulders, a rms, a b domen Fina steride: protect from sunlight; not to b e ha ndled b y pregna nt women; fema le hea lthca re workers must wea r gloves when ha ndling Sildena fil: Ta ke 1 hr b efore sexua l a ctivity Do not ta ke with nitra tes; not effective without sexua l stimula tion a nd a rousa l Report prolonged erection (longer tha n 4 hrs) immedia tely Do not discontinue testosterone a b ruptly Considera tions / Pa tient Educa tion Na tura l testosterone Synthetic testosterone Synthetic a na b olic steroids Androgen inhib itors Phosphodiestera se inhib itors Bla ck Box Wa rning All testosterone drugs: thromb oemb olic disorders; b e a wa re of seconda ry exposure to tra nsderma l gel a nd solution Ora l a nticoa gula nts; cyclosporine Nitra tes with ED drugs Azole a ntifunga l drugs Erythromycin; cla rithromycin Propra nolol; vera pa mil Intera ctions: Neutra lize ga stric a cidity Stimula te secretion of mucus, prosta gla ndins a nd b ica rb ona te from ga stric gla nds Acute relief of symptoms of: Peptic ulcer; ga stritis Ga stric hypera cidity; hea rtb urn Rena l fa ilure; electrolyte disturb a nces GI ob struction Dia rrhea (Mg prepa ra tions) Constipa tion (Al a nd Ca formula tions) Kidney stones (Ca ) Systemic a lka losis (w/a ny a nta cid) Reb ound hypera cidity (Ca when stopped a b ruptly) Milk-a lka li syndrome (Ca ) Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: T. cla ss: Antiulcer drugs P. cla ss: H2-receptor a nta gonists P. cla ss: Anta cids (Aluminum-, Ca lcium-, or Ma gnesium-conta ining or comb ina tion) Ga strointestina l Medica tions Anta cids Mg Ca rb ona te (Ga viscon liquid) Mg Hydroxide (Milk of Ma gnesia ) Mg Oxide (Ma g-Ox) Mg Trisilica te (Ga viscon ta b lets) Al Ca rb ona te (Ba sa ljel) Al hydroxide (Amphojel; Alterna GEL) Ca Ca rb ona te (Tums; Ma a lox a nta cid ca plets; extra strength Alkets a nta cid) Na b ica rb ona te (Alka -Seltzer) Na Citra te (Citra pH) Al hydroxide a nd Mg hydroxide (Ma a lox, Myla nta ) Anta cids ca use intera ctions b y 4 methods: Adsorption - reduces a b ility of other drugs to b e a b sorb ed Chela tion - chemica l ina ctiva tion of other drugs ↑stoma ch pH - will ca use ↑a b sorption of b a sic drugs a nd ↓a b sorption of a cidic drugs ↑urina ry pH - will ca use ↑excretion of a cidic drugs a nd ↓excretion of b a sic drugs Some a ffected drugs: Benzodia zepines; sulfonylurea s; va lproic a cid; a llopurinol Tetra cycline; thyroid hormones; corticosteroids Digoxin; hista mine a nta gonists; phenytoin Sa licyla tes; quinolone a ntib iotics Intera ctions: H2 Receptor Anta gonists Block the H2 receptor of a cid-producing pa rieta l cells GERD; PUD; erosive esopha gitis Upper GI tra ct b leeding Zollinger-Ellison syndrome Ca ution with liver a nd/or kidney dysfunction (ma y need to a djust dose) Mecha nism of Action: Indica tions: Contra indica tions: -tidine cimetidine (Ta ga met) ra nitidine (Za nta c) fa motidine (Pepcid) niza tidine (Axid, Ta za c) Hypotension (with IV a dministra tion) Hea da che; letha rgy Confusion/disorienta tion (older a dults) Impotence/gynecoma stia (cimetidine) ↑prola ctin secretion Thromb ocytopenia (ra nitidine a nd fa motidine) Adverse effects (Low incidence): Nonprescriptive sa lts ma de of a luminum, ma gnesium, ca lcium a nd/or sodium AKA H2RAs or H2 Receptor Blockers Most popula r drug for a cid-rela ted disorders Ava ila b le OTC Cimetidine - theophylline, wa rfa rin lidoca ine, phenytoin Any med tha t requires a n a cidic environment for ga stric a b sorption (such a s ketocona zole) Smoking Intera ctions: Ga strointestina l Medica tions Proton Pump Inhib itors (PPIs) Bind to the proton pump which prevents hydrogen ions from moving into stoma ch Ma y ca use a chlorhydria (without HCl a cid) Erosive esopha gitis Symptoma tic GERD (tha t does not respond to H2RAs) Active duodena l ulcers (short-term tx) Active b enign ga stric ulcers (short-term tx) Ga stric hypersecretory conditions NSAID-induced ulcers Stress ulcer prophyla xis None except known drug a llergy Mecha nism of Action: Indica tions: Contra indica tions: la nsopra zole (Preva cid) omepra zole (Prilosec) ra b epra zole (AcipHex) pa ntopra zole (Protonix) esomepra zole (Nexium) dexla nsopra zole (Dexila nt) Achlorhydria which ma y lea d to b a cteria l overgrowth, intestina l meta pla sia or hip fra cture Long-term use: osteoporosis; clostridium difficile infections; risk for fra ctures; pneumonia ; depletion of Mg++ Ma y increa se serum levels of dia zepa m a nd phenytoin With wa rfa rin - risk of b leeding Ketocona zole; a mpicillin; iron sa lts; digoxin Clopidogrel with omepra zole Sucra lfa te Food (PPIs should b e ta ken on empty stoma ch) Adverse effects (Low incidence): Intera ctions: T. cla ss: Antiulcer drugs P. cla ss: PPIs Sucra lfa te (Ca ra fa te) T. cla ss: Antiulcer drugs P. cla ss: GI Protecta nts or Antifla tulents Mucosa l protecta nt; a cts loca lly b y b inding to surfa ce of a n ulcer Stimula tes secretion of mucus a nd b ica rb ona te b a se Stress ulcers; esopha gea l erosions; PUD Known drug a llergy Mecha nism of Action: Indica tions: Contra indica tions: Simethicone (Mylicon) Helps ga s b ub b les b rea k into sma ller b ub b les to fa cilita te their expulsion Ga stric or intestina l ga s (fla tulence) Known drug a llergy None Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Be a wa re of a ll meds pt is ta king to determine a ny potentia l intera ctions Chewa b les - ma ke sure to chew thoroughly Liquid - sha ke well b efore a dministra tion For GERD or hypera cidity: Avoid b la ck pepper, ca ffeine, a lcohol, ha rsh spices a nd extremes in food tempera ture Anta cids: All meds must b e ta ken 1-2 hrs b efore or a fter a nta cids Quinolone a ntib iotics - must b e ta ken 2 hrs b efore/a fter a nta cids (a b sorption will decrea se b y 50% if not followed) Al-a nta cids a nd Mg-a nta cids will ca ncel ea ch other's a dverse side effects (switch to comb o if pt experiences dia rrhea or constipa tion) Ta ke with a t lea st 8 oz wa ter Considera tions / Pa tient Educa tion H2RAs: IV a dministra tion: monitor BP for hypotension Report b loody or b la ck stools PPIs: Ma ke sure swa llowing ca pa b ilities a re sufficient due to size of pill If pt ha s prob lems swa llowing ca psules, open a nd sprinkle over 1 TB a pplesa uce a nd swa llow immedia tely Sucra lfa te: Requires multiple da ily doses Give other meds 2 hrs b efore sucra lfa te Give 1 hr b efore mea ls a nd a t b edtime Na usea ; constipa tion; dry mouth Physica l interference (must time a dmin) Adverse effects: Intera ctions: None Intera ctions: Pt with dia rrhea a ssocia ted with a b a cteria l or pa ra sitic infection must not use a ntidia rrhea l drugs (will ca use orga nism to sta y in b ody) Ga strointestina l Medica tions Antidia rrhea ls Adsorb ents: coa t wa lls of GI tra ct a nd b ind b a cteria or toxin → excrete via stool; used for mild ca ses Prob iotics: restore b a la nce of norma l flora ; used for a ntib iotic-induced dia rrhea Anticholinergics: ↓rhythmic contra ctions a nd smooth muscle tone of the GI tra ct; used for severe ca ses Opia tes: reduce b owel motility → decrea ses tra nsit time a nd thus stool frequency; provides relief of recta l spa sms; used for severe ca ses Dia rrhea Mostly minor a nd depends on drug Constipa tion; da rk stools; urina ry retention Hea da che; dizziness; confusion Anxiety; drowsiness; letha rgy; N/V Mecha nism of Action: Indica tions: Adverse effects: Antimotility drugs Anticholinergics a tropine hyoscya mine Opia tes opium tincture pa regoric codeine diphenoxyla te lopera mide Adsorb ents: digoxin; quinidine; hypoglycemic drugs; wa rfa rin; methotrexa te; glipizide (with cholestyra mine) Anticholinergics: a nta cids; a ma nta dine; TCAs; MAOIs; opia tes; a ntihista mines Opia tes: CNS depressa nts; a lcohol; opioids; seda tive- hypnotics; a ntipsychotics Intera ctions: Adsorb ents a ctiva ted cha rcoa l a luminum hydroxide b ismuth sub sa licyla te cholestyra mine polyca rb ophil Prob iotics La ctob a cillus a cidophilus La ctob a cillus GG Sa ccha romyces b oula rdii Report c/o a b pa in/distention, b loody stools, hypoa ctivity to no b owel sounds; fever to HCP immedia tely Instruct pt to ta ke exa ctly a s prescrib ed a nd to monitor wt, fluid inta ke, dia rrhea frequency a nd cha nges in b owel pa tterns Bismuth sub sa licyla te will turn stool b la ck or gra y; do not ta ke with other sa licyla tes Ta b lets: ta ke with 6-8 oz wa ter Diphenoxyla te: if given with a tropine wa tch for overuse: dry mouth, a b pa in, ta chyca rdia , b lurred vision Diphenoxyla te: if given with lopera mide must provide lots of fluids; do not exceed ma ximum Considera tions / Pa tient Educa tion Any ma jor a cute GI condition Contra indica tions: IBS with dia rrhea (IBS-D) a losetron (Lotronex) rifa ximin (Xifa xa n) eluxa doline (Vib erzi) Drugs for Irrita b le Bowel Syndrome Mecha nism of a ction: serotonin receptor a nta gonist Bla ck Box Wa rning: serious GI a dverse rea ctions ma y occur Mecha nism of a ction: a ntib iotic; a lters b a cteria in gut Well-tolera ted Mecha nism of a ction: mixed opioid receptor a gonist; lessens b owel contra ctions Contra indica tions: b ilia ry duct ob struction; a lcohol a b use Alosetron: Rifa ximin: Eluxa doline: Mecha nism of a ction: chloride cha nnel a ctiva tor Contra indica tions: b owel ob struction Adverse effects: na usea ; dia rrhea ; a b pa in Contra indica tion: GI ob struction Adverse effects: dia rrhea ; a b pa in; fla tulence Lub iprostone: Lina clotide: IBS with constipa tion (IBS-C) lupriprostone (Amitiza ) lina cotide (Linzess) Alosetron: Given twice da ily Pt must b e provided FDA-a pproved medica tion guide Drug must b e discontinued a fter 4 weeks if no response Discontinue immedia tely if constipa ted or signs of ischemic colitis All IBS drugs: use with ca ution due to side effects Considera tions / Pa tient Educa tion One of the most misused OTC meds Not to b e used long-term except for the b ulk-forming type Ga strointestina l Medica tions La xa tives Bulk-forming: a b sorb wa ter in intestines which increa ses b ulk a nd distends b owel → b owel movement Emollient: wa ter a b sorb ed into stool a nd expa nds → b owel distention → b owel movement Stimula nt: stimula tes the nerves tha t innerva te the intestine → perista lsis; a lso increa ses fluid in colon → increa ses b ulk a nd softens stool Sa line: increa ses osmotic pressure in SI b y stopping wa ter a b sorption → wa tery stool Hyperosmotic: increa ses feca l wa ter content in LI Meds for OIC or b owel resection: Periphera lly a cting mu-opioid receptor a nta gonists Constipa tion Remova l of toxic sub sta nce from b ody Prep for colonic dia gnostic procedure/surgery Relistor: for hospice pts w/opioid-induced constipa tion Entereg: a fter GI resection surgery Mova ntik: opioid-induced constipa tion Ca ution: a cute surgica l a b domen; a ppendicitis symptoms; feca l impa ction; intestina l ob struction; undia gnosed a b pa in Fluid disturb a nces Electrolyte imb a la nces Ga s forma tion Skin ra sh Ab domina l b loa ting Cra mping, dia rrhea Increa sed thirst Bulk-forming: a ntib iotics; digoxin; sa licyla tes: tetra cyclines; wa rfa rin Minera l oil: decrea sed a b sorption of fa t-solub le vits Hyperosmotic: b a rb itura tes; genera l a nesthetics; opioids; a ntipsychotics La ctulose: ora l a ntib iotics Stimula nt: a ntib iotics; digoxin; nitrofura ntoin; sa licyla tes; tetra cyclines; ora l a nticoa gula nts Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects (va ry per med): Intera ctions: Sa line ma gnesium hydroxide ma gnesium sulfa te ma gnesium citra te Hyperosmotic polyethylene glycol la ctulose sorb itol glycerin Bulk-forming psyllium methylcellulose Emollient docusa te sa lts minera l oil Stimula nt senna b isa codyl Docusa te sa lts, emollients a nd sa line: ca ution in older pa tients Hyperosmotic: do not use in older pa tients Methylcellulose: mix thoroughly with 8 oz wa ter a nd drink immedia tely (will sta rt to congea l if left sitting) Docusa te: ta ke with 6 oz wa ter a nd drink 6-8 a dditiona l gla sses of wa ter da ily Bisa codyl: b est on empty stoma ch; do not chew/crush ta b lets; do not ta ke milk, a nta cids or juices with the dose or within 1 hr of ta king med Suppository: lub rica te suppository prior to insertion; encoura ge pt to lie on left side for 15-30 minutes a fter Mg-b a sed: very potent; used only in certa in situa tions Senna : ta ke meds a t lea st 1 hr a pa rt; ma y ta ke 6-12 hrs to see effects Educa te pt on potentia l for a b use w/la xa tives Inform pt to report a ny of the following: a b domina l distention; firm/ha rd a b domen; a b pa in; worsening or no improvement in symptoms; recta l b leeding; unrelieved constipa tion or dia rrhea ; fever; na usea ; vomiting; dizziness; muscle wea kness; muscle cra mping Considera tions / Pa tient Educa tion Meds for opioid-induced constipa tion (OIC) or b owel resection surgery (not OTC) methylna ltrexone (Relistor) a lvimopa n (Entereg) na loxegol (Mova ntik) Considera tions / Pa tient Educa tion Chemoreceptor trigger zone (CTZ): pa rt of b ra in involved in induction of na usea /vomiting Ga strointestina l Medica tions Antiemetics Anticholinergic: b lock AcH receptors to stop na usea - inducing signa ls to the CTZ a nd vomiting center Antihista mines: simila r to a nticholinergics b ut b lock H1 receptors Antidopa minergics: b lock dopa mine receptors in the CTZ Neurokinin Blockers: enha nce serotonin b lockers a nd glucocorticoids to inhib it chemo-induced emesis Prokinetic drugs: b lock dopa mine receptors in the CTZ Serotonin b lockers: b lock serotonin receptors in the GI tra ct, CTZ a nd vomiting center THC: ma jor psychoa ctive sub sta nce in ma rijua na : inhib itory effect on b ra in, ca using a ltera tion in mood a nd perception which relieves N/V Na usea /vomiting (including N/V a ssocia ted w/chemo) Motion sickness Intra cta b le hiccups Nonproductive cough Dela yed ga stric emptying GERD Gla ucoma (scopola mine a nd a ntihista mines) La cta tion; b rea st ca ncer Shock GI ob struction Coma ; seizures Dizziness; drowsiness Ta chyca rdia /b ra dyca rdia Blurred vision Dry mouth Urina ry retention Orthosta tic hypotension EPS Dia rrhea Anticholinergics: a ntihista mines a nd a ntidepressa nts Antihista mines: b a rb itura tes; opioids; hypnotics; tricyclic a ntidepressa nts; a lcohol Antidopa minergics: CNS depressa nts; a lcohol Metoclopra mide: a nticholinergics a nd a na lgesics; a lcohol Aprepita nt: wa rfa rin; ora l contra ceptives; a zole a ntifunga ls; cla rithromycin; diltia zem; nica rdipine; protea se inhib itors; vera pa mil; corticosteroids Mecha nism of Action: Indica tions (va ry per med): Contra indica tions (va ry per med): Adverse effects (va ry per med): Intera ctions: Anticholinergics (T. Cla ss: Mydria tics) scopola mine (Tra nsderm-Scop, Scopa ce) Antihista mines (T. Cla ss: Antihista mines) meclizine (Antivert) dimenhydrina te (Dra ma mine) diphenhydra mine (Bena dryl) hydroxyzine (Vista ril) Antidopa minergics (T. Cla ss: Antiemetics) prochlorpera zine (Compa zine) prometha zine (Phenerga n) Neurokinin Blockers (T. Cla ss Antiemetics) a prepita nt (Emend) Prokinetic Drugs (T. Cla ss: GI Stimula nts) metoclopra mide (Regla n) Serotonin Blockers (T. Cla ss: Antiemetics) dola setron (Anzemet) gra nisetron (Kytril) onda nsetron (Zofra n) pa lonosetron (Aloxi) Tetra hydroca nna b inoid (THC) drona b inol (Ma rinol) Diphenhydra mine: ca utiously a dministered via IV Meclizine: monitor BP often, especia lly if older pt Dry mouth a llevia ted with suga rless gum or ha rd ca ndy Prometha zine: check vita ls a nd monitor for EPS; a void a lcohol a nd ca ffeine Metoclopra mide: ta ke 30 minutes b efore mea ls a nd a t b edtime; wa tch for EPS (report immedia tely); long-term use a ssocia ted with ta rdive dyskinesia Scopola mine: tra nsderma l pa tch a pplied b ehind ea r; rota te sites often Gra nisetron: IV or ora l a dministra tion; tempora ry ta ste disorder ma y occur Drona b inol: cha nge positions slowly Educa te: inform pt a b out potentia l of drowsiness with a ntiemetic drugs; a void ta king with CNS depressa nts or a lcohol H1 Anta gonists (H1 Blockers): compete with hista mine for H1 receptors in smooth muscle surrounding b lood vessels a nd b ronchioles; commonly known a s a ntihista mines H2 Anta gonists (H2 Blockers): compete with hista mine for H2 receptors; a ct on GI system Ma na gement of na sa l a llergies, a llergic rhinitis or urtica ria Symptoms of the common cold; a llergic rea ctions Motion sickness; vertigo Pa rkinson's disea se (for a nticholinergic effects); sleep a id Not to b e used a s sole drug thera py during a cute a sthma tic a tta cks Na rrow-a ngle gla ucoma ; CHD; kidney dz; HTN; pregna ncy Bronchia l a sthma ; COPD; PUD; seizure disorders; BPH Fexofena dine: rena l impa irment Lora ta dine: not for <2 yrs Ca ution: impa ired liver function/rena l insufficiency; la cta ting mothers Drowsiness Anticholinergic effects: dry mouth; cha nges in vision; difficulty urina ting; constipa tion Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Reb ound congestion: when repea ted use of inha led decongesta nts lea ds to decrea sed thera peutic effect Dila tion of ca pilla ries Contra ction of smooth muscle Stimula tion of ga stric secretions Accelera tion of hea rt ra te Hista mines a re involved in: Respira tory Medica tions Antihista mines diphenhydra mine (Bena dryl) b romphenira mine (Bromfed) chlorphenira mine (generic) dimenhydrina te (Dra ma mine) meclizine (Antivert) prometha zine (Phenerga n) lora ta dine (Cla ritin) cetirizine (Zyrtec) deslora ta dine (Cla rinex) fexofena dine (Allegra ) H1 Anta gonists: H2 Anta gonists (see GI meds) Will intera ct with a llergy test (stop a ll meds 4 da ys b efore test) Phenytoin; erythromycin Ketocona zole; cimetidine Alcohol; MAOIs; CNS depressa nts Intera ctions: Decongesta nts Adrenergics-constrict the sma ll a rterioles tha t supply the upper respira tory tra ct→ ↓na sa l secretions Na sa l steroids- decrea se response of immune system to a ntigens Na sa l congestion a ssocia ted with a cute or chronic rhinitis, common cold, sinusitis, ha y fever or other a llergies Swelling of na sa l pa ssa ges Adrenergics: na rrow-a ngle gla ucoma , uncontrolled CVD, HTN, DB, hyperthyroidism Mecha nism of Action: Indica tions: Contra indica tions: ephedrine (generic) oxymeta zoline (Afrin) phenylephrine (Na sop, Suda fed) pseudoephedrine (Nexa fed, Zephrex) tetra hydrozoline (Tyzine) b eclometha sone dipropiona te (Becona se) b udesonide (Rhinocort) flunisolide (Na sa lide) flutica sone (Flona se) tria mcinolone (Na socort) ciclesonide (Omna ris) ipra tropium (Atrovent) Inha led a drenergics: Intra na sa l steroids: Intra na sa l a nticholinergic: Directly compete with hista mine for specific receptor sites Adrenergics - sympa thomimetics Anticholinergics - pa ra sympa tholytics Topica l corticosteroids - intra na sa l steroids 3 groups: Adrenergics- well-tolera ted; nervousness, insomnia , pa lpita tions, tremor Na sa l steroids- mucosa l irrita tion a nd dryness Systemic sympa thomimetic drugs a nd sympa thomimetic na sa l decongesta nts should not b e given together MAOIs; methyldopa Urina ry a cidifiers a nd a lka linizers Adverse effects: Intera ctions: H1 Receptors H2 Receptors Antihista mines ha ve a ntihista minic, a nticholinergic a nd seda tive properties Tra ditiona l: diphenhydra mine, b romphenira mine, chlorphenira mine, dimenhydrina te, meclizine, prometha zine Work b oth periphera lly a nd centra lly; ha ve a nticholinergic effects; less expensive; good for insomnia & motion sickness Nonseda ting: Lora ta dine, cetirizine, deslora ta dine, fexofena dine Developed to get rid of seda tive effects Work periphera lly; longer dura tion of a ction; a va ila b le OTC Two types of a ntihista mines: T. Cla ss: Antihista mines or a nticholinergic a ntiemetics Respira tory Medica tions Antitussives Opioids: direct a ction on cough center in b ra in; provide a na lgesia ; ha ve drying effect on mucosa Nonopioids: dextromethorpha n sa me MOA a s opioids without a na lgesic properties or CNS depressa nt; b enzona ta te MOA numb s the stretch receptor cells in the respira tory tra ct Cough tha t is ha rmful a nd/or nonproductive Codeine a nd hydrocodone: a lcohol use; CNS depression; a noxia ; hyperca pnia ; respira tory depression; IIP; impa ired rena l function; liver disea se; BPH; COPD Dextromethorpha n: hyperthyroidism; a dva nced ca rdia c a nd vessel disea se; HTN; gla ucoma Mecha nism of Action: Indica tions: Contra indica tions: Opioid codeine (comb o products: Tussa r SF, Rob itussin AC, others) hydrocodone (comb o products: Tussionex, others) Nonopioid dextromethorpha n (Ba lminil DM, Benylin DM, Delsym, or comb o products: Vicks Formula 44, Rob itussin DM, others) b enzona ta te (Tessa lon Perles) Codeine a nd hydrocodone: seda tion, na usea , vomiting, lighthea dedness, constipa tion Benzona ta te: dizziness, hea da che, seda tion, na usea , constipa tion, pruritus, na sa l congestion Dextromethorpha n: dizziness, drowsiness, na usea Codeine a nd hydrocodone: other opioids, genera l a nesthetics, tra nquilizers, seda tives, hypnotics, TCAs, a lcohol Adverse effects: Intera ctions: Be a wa re of a ll meds pt is ta king to determine a ny potentia l intera ctions; ta ke meds a s directed Tra ditiona l a ntihista mines: Ca ution in older a dults (wa tch for dizziness, confusion, seda tion, hypotension, irrita b ility) NOT to b e used in a cute a sthma a tta ck Best tolera ted with mea ls Dry mouth: chew/suck ha rd ca ndy or OTC throa t lozenges Do not ta ke with other OTC or prescrib ed cough/cold meds Monitor BP/vita ls a nd for pa ra doxica l rxns in older a dults Nonseda ting a ntihista mines: ↓dose for elderly or ↓rena l fnx Antitussives: Ma y experience drowsiness/dizziness Codeine - ma y depress b rea thing a nd respira tion Give a t evenly spa ced interva ls; do NOT mix w/a lcohol Considera tions / Pa tient Educa tion Decongesta nts: Monitor BP a nd HR ↑fluid up to 3 L/da y to help liquefy secretions Excessive use of spra ys/drops ma y lea d to reb ound congestion Report: Difficulty b rea thing; pa lpita tions, fever, tight chest, cha nges in sputum color, wea kness a nd a ny other unusua l a dverse effects Expectora nts: a void a lcohol a nd do not use for longer tha n 1 week Cough reflex - stimula ted when receptors in the b ronchi, a lveoli, & pleura a re stretched → signa l sent to cough center in b ra in → cough 2 cla sses: opioid a nd nonopioid Codeine a nd hydrocodone a re ra rely used a lone for cough; a lmost a lwa ys in comb o products Expectora nts gua ifenesin (Mucinex) most commonExpectora tion: coughing up a nd spitting out Expectora nts help remove excessive mucus tha t ha s a ccumula ted in respira tory tra ct Increa ses the hydra tion of respira tory tra ct Ma inta ins the sol la yer necessa ry for cilia ry clea ra nce Reduces the viscosity of mucus Productive cough a ssocia ted with common cold, b ronchitis, la ryngitis, pha ryngitis, influenza , mea sles Mecha nism of Action: Indica tions: Known drug a llergy Na usea , vomiting, ga stric irrita tion None Contra indica tions: Adverse effects: Intera ctions: T. Cla ss: Antitussives Bla ck Box Wa rning Opioids a re a ddictive a nd ca n depress respira tions T. Cla ss: Expectora nts Rela x a nd dila te a irwa ys b y stimula ting the b eta 2-a drenergic (respira tory) receptors in the lungs Prevention or relief of b ronchospa sm Hypotension; shock Uncontrolled HTN or ca rdia c dysrhythmia s ↑risk for stroke Mecha nism of Action: Indica tions: Contra indica tions: Rela x b ronchia l smooth muscle which ca uses dila tion of the b ronchi a nd b ronchioles - 3 cla sses Respira tory Medica tions Bronchodila tors Beta -a drenergic a gonists Anticholinergics Xa nthine deriva tives 3 cla sses: Insomnia ; restlessness; a norexia ; ca rdia c stimula tion; tremor Angina l pa in; va scula r hea da che HTN; hypotension Nonselective b eta b lockers MAOIs Hypoglycemic drugs Adverse effects (va ries per med): Intera ctions: AKA sympa thomimetic b ronchodila tors SABA used for a cute/rescue a sthma tx LABA never used for a cute a sthma tx Admin routes: ora l, injecta b le, inha led Short-a cting b eta a gonist inha lers (SABA): a lb uterol (Proventil, Ventolin) ephedrine (generic) epinephrine (Adrena lin) leva lb uterol (Xopenex) meta proterenol (Alupent, Meta prel) pirb uterol (Ma xa ir) terb uta line (Brethine) Ca tegorized b y onset of a ction:Beta -a drenergic a gonists Long-a cting b eta a gonist inha lers (LABA): sa lmeterol (Serevent) formoterol (Fora dil, Perforomist) a rformoterol (Brova na ) inda cterol (Arca pta Neoha ler) vila nterol (Breo Ellipta ; Anoro Ellipta ) oloda terol (Striverdi Respima t) Block Ach receptors on the b ronchia l tree → prevents b ronchoconstriction → a irwa y rela xa tion a nd dila tion occurs ↓secretions in COPD pts Prevent b ronchospa sm a ssocia ted w/COPD Mecha nism of Action: Indica tions: Dry mouth or throa t; na sa l congestion; hea rt pa lpita tions GI distress; urina ry retention; ↑intra ocula r pressure Hea da che; coughing; a nxiety Adverse effects: AKA long-a cting musca rinic a nta gonists (LAMAs)Anticholinergics ipra tropium (Atrovent) tiotropium (Spiriva ) a clidinium (Tudorza ) umeclidinium (Incruse Ellipta ) glycopyrrola te (Seeb ri)Known drug a llergy (including to a tropine) Ca ution: a cute na rrow-a ngle gla ucoma a nd prosta te enla rgement Contra indica tions: Other a nticholinergic drugs Intera ctions: Increa se levels of cAMP which ca uses b ronchodila tion Stimula te CNS which enha nces respira tory drive Asthma or COPD to dila te the a irwa y To ma na ge COPD Mild to modera te ca ses of a sthma (not a cute a sthma a tta ck) Mecha nism of Action: Indica tions: N/V; a norexia ; sinus ta chyca rdia Extra systole; pa lpita tions Ventricula r dysrhythmia s; hyperglycemia Adverse effects: Not used much due to intera ctions a nd va rying thera peutic levelsXa nthine Deriva tives theophylline (Theola ir, Slo-Bid) a minophylline (Phyllocontin, Truphylline) dyphylline (Lufyllin, Dylix) Uncontrolled ca rdia c dysrhythmia s; seizure disorders Hyperthyroidism; peptic ulcers Contra indica tions: Allupurinol; cimetidine; ma crolide a ntib iotics; quinolones; influenza va ccines; ora l contra ceptives; sympa thomimetics; rifa mpin; St. John's wort; ciga rette smoking Foods: cha rcoa l-b roiled, high-protein a nd low-ca rb ohydra te Intera ctions: T. Cla ss: Bronchodila tors T. Cla ss: Bronchodila tors T. Cla ss: Methylxa nthines Zileuton: Inhib its enzyme 5-lipoxygena se, necessa ry for leukotriene synthesis Monteluka st a nd za firluka st: Bind to the D4 leukotriene receptors in the respira tory tra ct tissues a nd orga ns Prophyla xis a nd long-term tx a nd prevention of a sthma Monteluka st - a llergic rhinitis NOT for a cute a sthma a tta cks Mecha nism of Action: Indica tions: Include leukotriene receptor a nta gonists a nd corticosteroids Respira tory Medica tions NonBronchodila ting Allergy to povidone, la ctose, tita nium dioxide or cellulose deriva tives Hea da che; na usea ; dizziness; insomnia ; dia rrhea Phenob a rb itol; rifa mpin; a spirin; erythromycin; wa rfa rin; propra nolol; theophylline Contra indica tions: Adverse effects: Intera ctions: In a sthma , leukotrienes ca use infla mma tion, b ronchoconstriction, a nd mucus production which lea ds to coughing, wheezing, a nd SOB Leukotriene Receptor Anta gonists monteluka st (Singula ir) za firluka st (Accola te) zileuton (Zyflo) Sta b ilize memb ra nes of WBCs to decrea se relea se of infla mma tory sub sta nces Enha nce a ctivity of b eta a gonists (e.g. a lb uterol) Persistent a sthma (Inha led) Severe or a cute a sthma (Systemic) Mecha nism of Action: Indica tions: Inha led - pha ryngea l irrita tion, coughing, dry mouth, ora l funga l infections (must rinse a fter use) High-dose IV or ora l a dministra tion - a drenocortica l insufficiency; ↑susceptib ility to infection; fluid a nd electrolyte disturb a nces; effects to CNS, endocrine system a nd connective tissues (Cushing's syndrome)→ MUST ta per slowly due to risk of a drena l suppression - Addisonia n crisis Adverse effects: AKA glucocorticoidsCorticosteroids b eclometha sone dipropiona te (Beclovent) b udesonide (Pulmicort Turb uha ler) ciclesonide (Omna ris) flunisolide (AeroBid) flutica sone (Flovent) mometa sone (Asma nex) tria mcinolone a cetonide (Azma cort) Inha led Inha led - hypersensitivity to glucocorticoids; sputum + for Ca ndida orga nisms; systemic funga l infection Contra indica tions: Antidia b etic drugs Cyclosporine; ta crolimus Itra cona zole Phenytoin Phenob a rb ita l Rifa mpin HCTZ a nd furosemide Intera ctions: prednisone (Prednisone Intensol, Ra yos) methylprednisolone (Medrol - ora l, Solu-Medrol - IV) Systemic T. Cla ss: Leukotriene Modifiers T. Cla ss: Corticosteroids Respira tory Medica tions All respira tory drugs: Ta ke a s prescrib ed a nd b y prescrib ed route Increa se fluid inta ke unless contra indica ted Pts with a sthma , b ronchitis, COPD - a void situa tions tha t lea d to worsening symptoms (a llergens, stress, smoking, etc) Bronchodila tors: Demonstra te proper method for a dministering inha led form a nd a llow time for return demo Metered Dose Inha ler (MDIs) - wa it 1-2 minutes b etween puffs; wa it 2-5 minutes b etween 2 different inha led meds Spa cer device: helps increa se a mount delivered Dry Powder Inha ler (DPIs) - deliver dry micronized powder with ea ch b rea th Neb ulizer - delivers droplets via sma ll mouthpiece or ma sk Beta a gonists: Overdosa ge ma y b e life-threa tening LABA - Not for a cute tx Ta ke with food to decrea se GI upset Do not crush or chew ora l susta ined-relea se ta b lets Instruct on epipen a s needed Assess respira tory sta tus, b rea th sounds a nd pulse oximeter rea dings b efore, during a nd a fter thera py Anticholinergics: Wa it 1-2 minutes b efore second dose Rinse mouth with wa ter immedia tely a fter inha led or neb ulizer drug Ipra tropium - used prophyla ctica lly Confirm no a llergy to soyb ea ns/pea nuts/legumes Encoura ge extra fluids Considera tions / Pa tient Educa tion Xa nthine Deriva tives: Ora l - ta ke with food Suppository forms need to b e refrigera ted No smoking Foods - a void cha rcoa l-b roiled, high-protein, low ca rb s Ta ke meds round-the-clock Report worsening a dverse effects immedia tely LTRAs: Monteluka st - conta ins a spa rta me a nd phenyla mine Ta ke on continuous schedule even if symptoms improve Ta ke monteluka st a t night Corticosteroids: Inha led - Ta ke every da y, rega rdless of how s/he feels Often ta ken with b ronchodila tor inha led drug - ta ke 2-5 minutes b efore corticosteroid Keep inha lers a nd neb ulizers clea n; cha nge filters Encoura ge pea k flow meter a nd journa ling Ora l hygiene a fter la st inha la tion - rinse with wa ter to prevent ora l funga l infections Prime b efore first use or if not used within 10 da ys Do not wa sh inha ler or get wet Disca rd b y da te on inha ler Systemic - Wa rn a b out Cushing's syndrome from excess levels Do NOT a b ruptly discontinue (Addisonia n crisis) Antia nxiety a nd Hypnotic Drugs Increa se the effectiveness of GABA (ma jor ca lming neurotra nsmitter in the CNS) Psychotropic Drugs Benzodia zepines (most common) Z-hypnotics Doxepin Suvorexa nt Buspirone Produce a ca lming effect Ca use seda tion a t higher doses Quick onset of a ction High potentia l for dependence Seda tion; relief of a gita tion or a nxiety Alcohol withdra wa l; insomnia Elderly due to risk for fa lls/b one fra ctures Those w/sub sta nce a b use disorders Pregna nt or b rea stfeeding women Ata xia ; seda tion; decrea sed cognitive function Ma ny: a lcohol, opioids, TCAs, a mong others Indica tions: Contra indica tions: Adverse effects: Intera ctions: Benzodia zepines dia zepa m (Va lium) clonozepa m (Klonopin) a lpra zola m (Xa na x) lora zepa m (Ativa n) Seda tive effect w/o a ntia nxiety, a nticonvulsa nt, muscle rela xa nt effects Fa ster onset tha n b enzodia zepines Short ha lf-lives Seda tion, insomnia Angioedema ; elderly; depression Sleepwa lking; a ta xia ; letha rgy; hea da che; a mnesia CNS depressa nts; opioids Indica tions: Contra indica tions: Adverse effects: Intera ctions: Z-Hypnotics zolpidem (Amb ien) za leplon (Sona ta ) eszopiclone (Lunesta ) Mela tonin - na tura lly occurring hormone only excreted a t night NOT cla ssified a s a scheduled sub sta nce Insomnia (specifica lly troub le fa lling a sleep) Severe hepa tic impa irment Severe sleep a pnea or severe COPD Pa tient ta king fluvoxa mine Hea da che, dizziness; depression Long-term: high levels of prola ctin a nd sexua l dysfunction CNS depressa nts, donepezil, opioids, a lcohol Indica tions: Contra indica tions: Adverse effects: Intera ctions: ra melteon (Rozerem) Insomnia (specifica lly difficulty ma inta ining sleep) Severe urina ry retention; MAOIs; other CNS depressa nts; seda ting a ntihista mines Drowsiness, dizziness, seizures, a ta xia , hypoglycemia Ba rb itura tes, CNS depressa nts, quinolones, clonidine, evening primrose oil, MAOIs, a lcohol Indica tions: Contra indica tions: Adverse Effects: Intera ctions: Doxepin doxepin (Silenor) flura zepa m (Da lma ne) tema zepa m (Restoril) tria zola m (Ha lcion) esta zola m (ProSom) qua zepa m (Dora l) Mela tonin Receptor Agonists -pa m; -la m Bla ck Box Wa rning Avoid using w/opioids when possib le; doxepin: not for children Mela tonin Receptor Agonists T. Cla ss = Antidepressa nts T. Cla ss = Hypnotics T. Cla ss = Hypnotics T. Cla ss = Anxiolytics or Hypnotics Mecha nism of Action Antia nxiety a nd Hypnotic Drugs, cont. Psychotropic Drugs Decrea ses a nxiety without strong seda tive-hypnotic properties; tolera ted b etter tha n b enzodia zepines Not a CNS depressa nt Anxiety Within 14 da ys of MAO inhib itor thera py Severe rena l or hepa tic impa irment Dizziness; insomnia ; nervousness Hea da che; depression Azole a ntifunga ls; gra pefruit juice; a lcohol CNS depressa nts; MAO Inhib itors Indica tions: Contra indica tions: Adverse effects: Intera ctions: Buspirone Acts a s a n orexin receptor a nta gonist Orexin - neuropeptide tha t promotes norma l wa kefulness Insomnia Na rcolepsy; severe hepa tic impa irment Ob structive sleep a pnea ; severe COPD Da ytime impa irment, worsening depression Ab norma l thinking/b eha vior ↑suicida l idea tion; sleep pa ra lysis CNS depressa nts Indica tions: Contra indica tions: Adverse effects: Intera ctions: Suvorexa nt suvorexa nt (Belsomra ) b uspirone (BuSpa r) Benzodia zepines: monitor for side effects a nd note tha t pa ra doxica l rea ctions ma y occur (exa ct opposite of intended response); educa te on risk of dependence Buspa r: 2-4 weeks to see full effects Do not ha ndle hea vy equipment or drive until pt knows how he/she rea cts Avoid a lcohol a nd other a ntia nxiety drugs; a void ca ffeine Ta ke meds with mea ls to a void a ny GI upset; except Rozerem a nd Silenor All hypnotics: ta ke b efore b edtime Doxepin: dilute with 4 oz fluids (not ca rb ona ted) a nd a void direct sunlight Antidepressa nt Drugs Possib le MOA is a n increa se in serotonin, norepinephrine a nd dopa mine SSRIs Na SSAs Serotonin Modula tor SARIs NDRIs SNRIs TCAs MAOIs Depression Within 14 da ys of stopping MAO inhib itor Thiorida zine or mesorida zine Indica tions: Contra indica tions: SSRIs - Selective Serotonin Reupta ke Inhib itors Fluoxetine (Proza c) Sertra line (Zoloft) Pa roxetine (Pa xil) Cita lopra m (Celexa ) Escita lopra m (Lexa pro) Fluvoxa mine (Luvox) Sexua l dysfunction; N/V; serotonin syndrome (see next pa ge) Ma ny! Antipsychotics, a ntiemetics, TCAs, lithium, MAOIs, St. John's wort Adverse effects: Intera ctions: Block the reupta ke of serotonin ma king more of it a va ila b le Bla ck Box Wa rning Ma y increa se risk of suicida l thoughts in children & young a dults T. Cla ss = Antidepressa nts T. Cla ss = Hypnotics T. Cla ss = Anxiolytics Considera tions / Pa tient Educa tion Mecha nism of Action Psychotropic Drugs Antidepressa nt Drugs, cont. Norepinephrine & Serotonin Specific Antidepressa nt Anta gonize (b lock) a drenergic a utoreceptors Minima l sexua l dysfunction a nd improved sleep Depression; a nxiety Within 14 da ys of stopping MAO inhib itor Seda tion, a ppetite stimula tion, weight ga in Dia zepa m, other CNS depressa nts; St. John's wort; a lcohol Indica tions: Contra indica tions Adverse effects: Intera ctions: Na SSAs mirta za pine (Remeron) Ma y help geria tric pts increa se cognitive deficits Depression Fa mily history of b ipola r disorder Pts ta king diuretics (ca ution) Constipa tion; N/V; pruritus; hypona tremia ; hypoma nia /ma nia (ra re) NSAIDs, wa rfa rin, diuretics, MAO inhib itors St. John's wort, a lcohol Indica tions: Contra indica tions: Adverse effects: Intera ctions: Serotonin Modula tor & Stimula tor vortioxetine (Trintellix) Serotonin Anta gonist a nd Reupta ke Inhib itors Depression Brexipipra zole - depression from schizophrenia Nefa zodone - Pre-existing liver prob lems Brexpipra zole - Elderly pts w/dementia -rela ted psychosis (↑ risk of dea th) Seda tion, hea da che, dizziness, orthosta tic hypotension; pria pism (prolonged erection) Dry mouth, b lurred vision; a ka thisia , wt ga in Anticholinergics; CNS depressa nts Ampheta mines; a ntipsychotics St. John's wort, gra pefruit juice Indica tions: Contra indica tions: Adverse effects: Intera ctions: SARIs nefa zodone (formerly Serzone) tra zodone (Oleptro - formerly Desyrel) b rexpipra zole (Rexulti) Norepinephrine Dopa mine Reupta ke Inhib itor Does not ca use sexua l dysfunction side effects Wellb utrin - Depression Zyb a n - smoking cessa tion Seizure disorder Bulimia or a norexia nervosa (pa st or present) Pt in midst of a b rupt cessa tion of a lcohol or seda tives Insomnia , tremor, a norexia , wt loss Ama nta dine, levodopa Other a ntidepressa nts Beta b lockers MAO inhib itors Alcohol Indica tions: Contra indica tions: Adverse effects: Intera ctions: NDRIs b upropion (Wellb utrin a nd Zyb a n) Ra re b ut life-threa tening event Due to over-a ctiva tion of serotonin receptors from too high a dose or intera ction with other drugs (usua lly MAOI) S/S: a b pa in, dia rrhea , swea ting, fever, ta chyca rdia , eleva ted BP, delirium, muscle spa sms, irrita b ility, mood cha nge Pt must discontinue a ll SSRIs for 2-5 weeks b efore sta rting MAOI Serotonin Syndrome Psychotropic Drugs Antidepressa nt Drugs, cont. Serotonin Norepinephrine Reupta ke Inhib itors Ma y ha ve thera peutic effects on neuropa thic pa in Desvenla fa xine - prima ry a ctive meta b olite of venla fa xine (therefore simila r effects) Depression; GAD Within 14 da ys of stopping MAO inhib itor Insomnia ; a nxiety; fa tigue; GI b leeding; wt loss; hypertension, ta chyca rdia NSAIDs, wa rfa rin, a lcohol use, a nticoa gula nts, MAO inhib itors Indica tions: Contra indica tions: Adverse effects: Intera ctions: SNRIs venla fa xine (Effexor) desvenla fa xine (Pristiq) duloxetine (Cymb a lta ) Monoa mines- include norepinephrine, epinephrine, dopa mine, serotonin, tyra mine (in food) MAO- enzyme tha t destroys monoa mines MAOIs - inhib it a ction of MAO Prob lem: Liver uses MAO enzymes to degra de monoa mines in food, especia lly tyra mine Tyra mine ca n produce significa nt va soconstriction → ↑ BP a nd threa t of hypertensive crisis Pt ta king MAOIs a t risk of monoa mine toxicity a nd hypertensive crisis especia lly when comb ined w/certa in drugs a nd foods Pa rkinson's disea se; unconventiona l depression HTN; CHF; Liver dz; recurrent hea da ches Orthosta tic HTN, wt ga in, edema ; sexua l dysfnx SSRIs; meperidine Indica tions: Contra indica tions: Adverse effects: Intera ctions: isoca rb oxa zid (Ma rpla n) phenelzine (Na rdil) TCAs - Tricyclic Antidepressa nts MAOIs - Monoa mine Oxida se Inhib itors selegiline (EMSAM) tra nylcypromine (Pa rna te) Widely used b efore SSRIs; no longer considered first- line Ha ve more side effects tha n SSRIs; ta ke longer to rea ch optima l level; fa r more letha l in overdose Insomnia ; neuropa thic pa in syndromes Within 14 da ys of stopping MAO inhib itor Pregna ncy; recent MI; history of seizures Constipa tion, urina ry retention; drowsiness; dry mouth; dysrhythmia s Ma ny! Ba rb itura tes, CNS depressa nts, MAOIs Indica tions: Contra indica tions: Adverse effects: Intera ctions: a mitriptyline (Ela vil) clomipra mine (Ana fra nil) imipra mine (Tofra nil) trimipra mine (Surmontil) a moxa pine (Amoxa pine Ta b lets) desipra mine (Norpra min) nortriptyline (Pa melor, Aventyl) protriptyline (Viva ctil) Discuss: All side effects of ea ch medica tion; instruct on wha t to look for a nd when to ca ll HCP Potentia l for ↓lib ido All potentia l drug a nd lifestyle (e.g. a lcohol) intera ctions Need to ta ke medica tion exa ctly a s prescrib ed a nd do not stop a b ruptly Ma y not see full effect for severa l weeks Ta ke ca re when driving a nd opera ting la rge ma chinery MAOIs: provide list of foods to a void a nd review s/s of hypertensive crisis Review s/s of serotonin syndrome Usua lly occurs w/in 15-90 minutes of ingesting prob lema tic food Ea rly s/s: Irrita b ility, a nxiety, flushing, swea ting, severe hea da che; BP > 180/110 La ter s/s: a nxious, restless, fever which b ecomes severe, followed b y seizures a nd coma or dea th Hypertensive Crisis Considera tions / Pa tient Educa tion Psychotropic Drugs Mood Sta b ilizers By a ltering electrica l a ctivity, lithium is a threa t to a ll b ody functions regula ted b y electrica l currents Ha s low thera peutic index: must monitor b lood levels on a regula r b a sis Helps sta b ilize electrica l a ctivity in neurons Reduces excita tory neurotra nsmitter gluta ma te Bipola r (ma nic-depressive) disorder Dehydra tion; sodium imb a la nce Ma jor rena l or ca rdiova scula r disea se Pregna nt; b rea stfeeding Bra dyca rdia ; tremors; disturb a nces in fluid b a la nce (polyuria , edema ); seizures; coma Hypothyroidism from long-term use GI discomfort; confusion; dysrhythmia Thia zide diuretics; ACE inhib itors; NSAIDs Mecha nism of Action: unknown, possib ly: Indica tions: Contra indica tions: Adverse effects: Intera ctions: Lithium lithium (Eska lith, Lithob id) Anticonvulsa nt/Antiepileptic Drugs Va lproa te - Ca rb a ma zepine - La motrigine va lproa te (Depa kote, Depa kene) ca rb a ma zepine (Equetro, Tegretrol) la motrigine (La micta l) Bla ck Box Wa rning Lithium toxicity ca n occur close to thera peutic levels Ma y ta ke 7 - 21 da ys to rea ch thera peutic b lood levels 600 - 1200 mg/d in 2-3 doses (to sta rt) Increa se every few da ys b y 300 mg/d; Ma x dose 1800 mg/d Goa l b lood serum level 0.6-1.2 mEq/L; should not exceed 1.5 mEq/L Lithium levels mea sured 5 da ys a fter b eginning a nd a fter a ny dosa ge cha nge; then q month until 6 mo then q 3 months Discuss: Ma inta in fluid inta ke 1500-3000 mL/d Ma inta in consistent Na + inta ke ea ch da y (increa sed Na + lea ds to lower levels of lithium) Ta ke meds with mea ls Alter electrica l conductivity in memb ra nes Reduce firing ra te of neurons in b ra in Bipola r disorder (a cute ma nia or ma intena nce a nd depression, depends on medica tion) Hepa tic disea se; pregna ncy Bone ma rrow suppression Within 14 da ys of stopping MAOI Tremors; wt ga in; seda tion; occa siona lly: thromb ocytopenia , pa ncrea titis, hepa tic fa ilure, b irth defects Anticholinergic (dry mouth, constipa tion, urina ry retention, b lurred vision); orthosta sis, seda tion; a ta xia ; ra sh → Importa nt! Ra sh ma y progress to Stevens-Johnson syndrome or exfolia tive derma titis (life-threa tening) Va ries depending on med: a nticoa gula nts; MAOIs; a spirin; a lcohol; gra pefruit juice Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Intera ctions: Bla ck Box Wa rning Pa ncrea titis; feta l hepa totoxicity; a pla stic a nemia Must ob ta in b a seline liver function tests a nd CBC; monitor la b s a nd thera peutic levels periodica lly Must ob ta in b a seline EKG a nd electrolyte levels Instruct: Asia n descent requires genetic testing (↑ risk for ra sh) Do not stop med a b ruptly Monitor for ra sh a nd notify HCP if a ppea rs Med ma y ca use sensitivity to sun Ta ke meds with food to decrea se GI upset T. Cla ss = Antima nics T. Cla ss = Anticonvulsa nts Considera tions / Pa tient Educa tion Considera tions / Pa tient Educa tion Psychotropic Drugs Drug Trea tment for ADHD Psychostimula nts methylphenida te (Rita lin, Da ytra na ) dextroa mpheta mine (Addera ll, Vyva nse) Nonstimula nts a tomoxetine (Stra ttera ) (T. Cla ss = ADHD drugs) gua nfa cine (Intuniv) (T. Cla ss = Antihypertensives) clonidine (Ka pva y) (T. Cla ss = Antihypertensives) Ma insta y of trea tment for ADHD Block reupta ke of norepinephrine a nd dopa mine ADHD; na rcolepsy CVD; HTN (modera te to severe) Hyperthyroidism Within 14 da ys of stopping MAOI Gla ucoma Hea da che, insomnia , a gita tion, seizures Pa lpita tions, a rrhythmia s Dry mouth, N/V, wt loss, growth suppression Anta cids; MAOIs; thia zides Ca ffeine; a lcohol; ephedra Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Intera ctions: Bla ck Box Wa rning High potentia l for a b use Norepinephrine reupta ke inhib itor or a lpha -2 a drenergic a gonist ADHD Hea rt prob lems; recent MI; HTN; ta chyca rdia Within 14 da ys of stopping MAOI ↓a ppetite, fa tigue, dizziness Bra dyca rdia , severe reb ound HTN, N/V Alb uterol; MAOIs; ma ny a ntidepressa nts Beta b lockers; Ma hua ng; ca psicum Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Intera ctions: Stimula nts: Instruct to give la st dose 4-6 hrs b efore b edtime Monitor children for continued physica l growth a nd a ggressive b eha vior Monitor b lood pressure Nonstimula nts: Instruct to report: SOB, chest pa in Monitor BP a nd pulse Do not stop a b ruptly (to a void severe reb ound HTN) Antipsychotic Drugs First-Genera tion Antipsychotics Second-Genera tion Antipsychotics AKA 'Conventiona l' 'Typica l' Not used a s much a s SGAs due to nega tive side effects; however chea per tha n SGAs a nd do not ca use meta b olic syndrome Block dopa mine receptors Delusions a nd ha llucina tions of schizophrenia Mecha nism of Action: Indica tions: Contra indica tions/Intera ctions: See SGAs Ma ny, including a nticholinergic side effects (see next pa ge); Extra pyra mida l Symptoms (EPS): a cute dystonic rea ctions, pa rkinsonism, a ka thisia , ta rdive dyskinesia ; must monitor for involunta ry movements a fter a dministering Adverse effects: chloroproma zine (Thora zine) fluphena zine (generic) perphena zine (generic) prochlorpera zine (Compa zine) trifluopera zine (generic) thiorida zine (generic) thiothixene (Na va ne) ha loperidol (Ha ldol) pimozide (Ora p) First-Genera tion Antipsychotics (FGAs) Bla ck Box Wa rning Older a dults with dementia : ↑risk of dea th T. Cla ss = Antipsychotics T. Cla ss = CNS Stimula nts Considera tions / Pa tient Educa tion Antipsychotic Drugs, cont. Psychotropic Drugs Considered first-line trea tment for psychotic illness Ta rget b oth positive a nd nega tive symptoms of schizophrenia Produce fewer EPS symptoms a nd do not ca use ta rdive dyskinesia Ma y ↑risk of meta b olic syndrome (↑weight, ↑ BG a nd ↑TG) Grea test risk w/cloza pine a nd ola nza pine Block dopa mine a nd serotonin receptors Psychotic illness, most commonly schizophrenia Ta rdive dyskinesia ; pa rkinsonism; previous neuroleptic ma ligna nt syndrome Elderly pa tient with dementia Pituita ry prola ctinoma Ta y Sa chs disea se Gla ucoma ; liver disea se Severe neutropenia ; b one ma rrow depression Hyperlipidemia ; dia b etes mellitus Wt ga in a nd sub sequent meta b olic syndrome QTc prolonga tion; seizures Some extra pyra mida l side effects Myoca rditis; a gra nulocytosis; ca ta ra cts Sexua l side effects Orthosta tic hypotension; seda tion Anticholinergics Antihypertensives Benzodia zepines; opioids Protea se inhib itors Smoking (ma y lower SGA levels); a lcohol Mecha nism of Action: Indica tions: Contra indica tions: Adverse Effects: (va ries per medica tion) Intera ctions: cloza pine (Clora zil) risperidone (Risperda l) quetia pine (Seroquel) ola nza pine (Zyprexa ) zipra sidone (Geodon) a ripipra zole (Ab ilify) pa liperidone (Invega ) iloperidone (Fa na pt) lura sidone (La tuda ) a sena pine (Sa phris) Adherence a nd proper dosa ge critica l Alterna te intra muscula r injection sites Mea sure serum levels during follow-up visits Instruct: Avoid extreme perspira tion Ora l solutions - do not ta ke with soda or tea Report a ny unusua l s/s Suga r-free ha rd ca ndy or gum for dry mouth Smoking cessa tion will ↑cloza pine concentra tion Geodon & La tuda - ta ke with food Sa phris - a dministered sub lingua l; a void food/drink for 10 minutes a fterwa rds Fa na pt - needs slow dosa ge titra tion over 1st few da ys Extra pyra mida l Side Effects (EPS): Acute dystonia - Sudden, susta ined contra ction of one or severa l muscle groups, usua lly hea d or neck; not da ngerous unless involves a irwa y Aka thisia - motor restlessness, ca uses ina b ility to sta y still Pa rkinsonism - group of symptoms tha t looks like Pa rkinson's disea se (tremor, ga it impa irment, etc) Ta rdive dyskinesia - involunta ry rhythmic movements The Ab norma l Involunta ry Movement Sca le (AIMS) is used to identify a nd tra ct involunta ry movements Trea ted with va lb ena zine (Ingrezza ) Anticholinergic side effects: Urina ry retention, dila ted pupils, constipa tion, b lurred nea r vision, ta chyca rdia , dry mucous memb ra nes, ↓perista lsis Anticholinergic toxicity: Grea test risk for older a dults a nd those on multiple a nticholinergic drugs S/S: Autonomic nervous system insta b ility, delirium with a ltered menta l sta tus, ma y include ha llucina tions Neuroleptic ma ligna nt syndrome (Seen with FGAs mostly): S/S: ↓consciousness a nd responsiveness; ↑muscle tone (muscle rigidity); a utonomic dysfunction Life threa tening medica l emergency! Agra nulocytosis: Mostly a ssocia ted with cloza pine Neutropenia ma y a lso develop a nd b e fa ta l S/S: infection (fever, chills, sore throa t) Prolonga tion of QT interva l: Ca rdia c emergency ECG performed on a ll pts prior to sta rting a ntipsychotic to check for existing QT prolonga tion Liver impa irment: Seen mostly with FGAs, usua lly in 1st weeks of thera py Monitoring of liver function essentia l S/S: yellowish skin a nd eyes, a b pa in, a scites, vomiting, swelling in lower extremities, da rk urine, pa le or ta r- colored stool, ea sy b ruising, itchy skin, chronic fa tigue, na usea , loss of a ppetite Side Effects of Antipsychotic Drugs Second-Genera tion Antipsychotics (SGAs, 'Atypica l') T. Cla ss = Antipsychotics Considera tions / Pa tient Educa tion Psychotropic Drugs Alzheimer's Disea se Drug Trea tment Cholinestera se Inhib itors NMDA Receptor Anta gonist NMDA Receptor Anta gonist Mema ntine (Na menda )Cholinestera se Inhib itors Donepezil (Aricept) Riva stigmine (Exelon) Ga la nta mine (Ra za dyne) All medica tions produce only ma rgina l improvement in cognition a nd functioning. Effectiveness wa nes a fter 1-2 yrs. Memory loss of Alzheimer's is a ttrib uted to insufficient a cetylcholine Cholinestera se: the enzyme tha t b rea ks down a cetylcholine Cholinestera se inhib itors: ina ctiva te cholinestera se so tha t more a cetylcholine is a va ila b le Mild to modera te Alzheimer's Pts ta king NSAIDs; COPD; rena l fa ilure N/V, dia rrhea , b ra dyca rdia , syncope, UTI Anticholinergics; ca rb a ma zepine; NSAIDs Amitriptyline; quinidine; a ntipsychotics Beta b lockers; smoking Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Intera ctions: The neurotra nsmitter gluta ma te pla ys a role in informa tion processing, stora ge, a nd retrieva l; too much ca n b e destructive to neurons Blocks NMDA (N-methyl-D-Aspa rta te) receptors to regula te the a ctivity of gluta ma te Typica lly a dded a fter trying cholinestera se inhib itor Modera te to severe Alzheimer's (not mild) Ca ution in pt w/seizures or CVD, hepa tic fa ilure Aggression, a nxiety, hea rt fa ilure, GI distress Cimetidine; hydrochlorothia zide; quinidine Alcohol, nicotine Mecha nism of Action: Indica tions: Contra indica tions: Adverse effects: Intera ctions: Educa te: Med does not a lter disea se, just improves symptoms Report significa nt cha nges in s/s Avoid OTC cold or sleep remedies Ma y need to ta ke with food to ↓GI side effects Monitor for ca rdia c complica tions, GI b leeds, pt weights T. Cla ss = Anti- Alzheimer Drugs Considera tions / Pa tient Educa tion","libVersion":"0.3.2","langs":""}